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Abstract 
Background: Infertility can affect women’s well-being, self-esteem, relationships and sexual 
satisfaction. Explanations for these effects are, however, speculative as few studies have 
examined women’s own reports of their experiences of infertility. 
Aims: The review therefore aimed to systematically examine qualitative studies of women’s 
lived experiences of infertility within modern Western cultures.  
Methods: Meta-ethnography was used to select and synthesise the studies. Articles published 
between 2000 and 2011 were searched for in EMBASE, MEDLINE, CINAHL and 
PsychINFO. Reference lists and journals of selected articles were also hand searched. Eight 
studies were identified for inclusion. Quality was assessed using a rating scale based on 
Walsh and Downe’s (2006) quality rating framework. 
Results: Six themes were identified; feeling different, compromised female identity, 
maintaining hope, sensitivity of professional support, developing a new life, and affected 
intimate relationships. Together these suggest that Western cultural expectations remain 
focused on traditional family patterns and roles. Infertility becomes a central focus for these 
women, with hope of pregnancy being persistent beyond an active decision to concentrate on 
other areas of life.  
Conclusions: The need for professionals to consider the emotional impact of infertility and 
the potential benefits of social support are identified. Further research focusing on infertility 
in different contexts is advised.   
 
Key words: Qualitative systematic review, lived experience, infertility, cultural expectations  
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Introduction 
Around 8-10% of couples are thought to experience difficulties with fertility (Boivin, 
Bunting, Collins & Nygren, 2007). Despite advances in medical treatment, success of 
interventions for infertility remains limited, with around 30-40% of couples remaining 
involuntarily childless after medical treatment (Pinborg, Hougaard, Nyboe Andersen, Molbo 
& Schmidt, 2009; U.S. Department of Health and Human Services, 2004). A wide range of 
negative emotions, such as stress, anxiety and depression are commonly reported as 
psychological responses to infertility (Demyttenaere et al., 1998; Verhaak et al., 2007; 
Volgsten, Skoog Svanberg, Ekselius, Lundkvist & Sundstrom Poromaa, 2008). Literature has 
shown that infertility and its treatment can affect self-esteem, relationships, sexual 
satisfaction and psychological well-being (Bergart, 2000). Women are generally thought to 
be more affected by infertility than men, reporting similar levels of psychological distress to 
those who have physical illnesses such as cancer (Chen, Chang, Tsai & Juang, 2004; Domar, 
Zuttermeister & Friedman, 1993; McCarthy, 2008).  
Becoming a parent is seen as a natural part of life by the majority of people 
(Johansson & Berg, 2005). Indeed, Carter and McGoldrick’s (1989) traditional family 
lifecycle model makes the assumption that individuals go through eight life stages, including 
parenting young children and adolescents, children leaving the family home, and becoming 
grandparents. Infertility has therefore been conceptualised as a life crisis where an 
individual’s assumptions about their lives and their world views can be challenged, leading to 
a sense of loss (Diamond, Kezur, Meyers, Schaf & Weinshel, 1999; Greil, 1997).  
Infertility, however, is thought to encompass recurrent losses of future dreams, of 
parenthood, and of control over one’s body (Glazer & Cooper, 1988). In keeping with Carter 
and McGoldrick’s model, these losses are thought to become particularly pertinent at certain 
life stages. Wirtberg, Müler, Hogström, Tronstad and Lalos (2007) therefore proposed that, 
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although infertility may cause individuals to adjust their expectations and world views, crisis 
models are not sufficient to explain individuals’ experiences of infertility as the recurring 
nature of associated stressful events means that adaptation and resolution are difficult.  
Becker and Nachtigall (1994) proposed that pronatalist ideologies in Western 
cultures, which link social worth to having children and consider biological parenthood to be 
optimal, have led to childlessness being considered abnormal. This is in keeping with Miall 
(1989) who reported that those who experience infertility may be stigmatised. Fisher (1992) 
suggests that women may feel under more pressure to conform to societal ideals than men, 
which may also help to explain why they have been found to experience higher levels of 
distress about infertility. 
  These explanations, however, are somewhat speculative. Most of the research on 
infertility focuses on quantitative methods and on diagnostic criteria for psychiatric indicators 
of distress rather than exploring individuals’ lived experiences (Greil, 1997, McQuillan, 
Greil, White & Jacob, 2003). The aim of qualitative research is to ‘provide an in-depth 
understanding of people’s experiences, perspectives and histories in the context of their 
personal circumstances and settings’ (Spencer, Richie, Lewis & Dillon, 2003, p.3). Such an 
approach offers the possibility of providing insight into the lived experience of infertility and 
for the delivery of effective infertility care (Dyer, Abrahams, Hoffman & van der Spuy, 
2002). Qualitative studies have considerable potential to provide insight into such lived 
experience, however there has been no proper review to determine, as a whole, what the data 
shows. Further, qualitative studies adopt a range of methods and also differ in quality, 
therefore some may be more helpful in providing insights into people’s experiences than 
others.   
This study aims to systematically review qualitative research on the experience of 
infertility, synthesising the data whilst taking account of methodological quality. Drawing out 
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themes from qualitative studies could offer theoretical insights and help develop more 
sensitive supports or interventions, based on an understanding of individual’s experiences. 
Examining people’s own experiences of being infertile is also in line with broader initiatives 
to gather service-user perspectives to inform health care and service development (e.g. 
Scottish Executive’s, 2006, Delivering for Health).  
Given the different psychological consequences for men and women indicated in the 
literature, this study aims to review only women’s experiences. Only those who have not had 
a biological child through the use of reproductive technologies are included, as retrospective 
accounts may have been affected by having become biological mothers. Having had a child 
after infertility treatment may result in women feeling less different from others, hence their 
experiences may differ from those who remain infertile. Further, only studies from Western 
cultures are included to help maintain a homogeneous sample and to help elucidate the link 
between women’s views of infertility and Western cultural notions of female identity. Such 
cultural beliefs, however, are historical and, as Ulrich and Weatherall (2000) have noted, 
there may now be a changing pattern of child bearing as more women are working and delay 
having children until they have developed their careers. For this reason the review focused on 
papers published from 2000 onwards.  
 
Objective 
The review aimed to facilitate a greater understanding of women’s experiences of 
infertility in the current social context by identifying central themes of importance to emerge 
from qualitative studies, and exploring any discrepancies that were found.  The review also 
aimed to assess the methodological quality of the reviewed studies and consider the 
implications of this for the interpretation of findings.  
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Research question 
What is the lived experience of women who are infertile? 
 
Method 
Search strategy 
Qualitative research can be difficult to identify using electronic databases and 
bibliographic database indexing systems’ thesaurus terms are of limited value for qualitative 
research (Barroso et al, 2003; Evans, 2002; Shaw et al, 2004). However, it remains good 
practice to complete a robust search, with transparency being vital (Walsh & Downe, 2005). 
Barbour and Barbour (2003) recommend that, due to the iterative nature of qualitative 
research, literature searches should be broad and inclusive. A broad search strategy using free 
text was therefore employed to encompass the diversity of possible themes.  
The EBSCO host was used to search CINAHL and PsychINFO databases, and OVID was 
used to search EMBASE and MEDLINE databases. All searches were completed on the 23rd 
September 2011 using the following terms: 
1. Qualitative OR grounded theory OR interpretative phenomenological OR narrative 
OR thematic analysis OR social constructionis$ OR phenomenolog$ OR experience$ 
OR content analysis OR focus group$ OR grounded OR interview$ OR ethnograph$ 
2. Infertility OR involuntary childlessness OR female infertility OR infertile 
3. 1. AND 2. 
Searches were limited to studies using human participants, and to those published in English. 
 
Studies yielded in the electronic search were compared to the inclusion and exclusion 
criteria in a three step process; comparing against study title, abstract and full text. Eight 
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studies were identified in the search (see Figure 1 for flowchart of search results and Table 1 
for study details). 
In order to ensure the sensitivity of the search, reference lists from all included 
articles were manually reviewed. This is suggested by Walsh and Downe (2005) who note 
that electronic searches may not identify all relevant qualitative studies. Four further articles 
were identified by their title in this search, however all were discounted after reviewing their 
abstracts. The journals which published all selected articles were also hand searched using the 
same three step process, with no additional articles being identified. 
 
Inclusion and exclusion criteria 
Inclusion criteria 
- Human participants 
- Female participants 
- Participants aged 16 and over 
- Participants live in Western cultures 
- Participants have undergone treatment for infertility 
- Participants remain biologically childless 
- Uses qualitative research methodology  
- Published in the English language 
- Published between 1st January 2000 and 23rd September 2011 
- Published in a peer reviewed journal 
- Aimed to explore some aspect(s) of women’s lived experiences of being infertile 
 
Exclusion criteria 
- Primarily quantitative in design, including only elements of qualitative methodology 
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- Unpublished, case study or book chapter 
- Focuses on the experiences of male participants only 
- If both male and female participants are included, it is not possible to separate female 
participant data  
- Participants have become biological mothers  
- Participants have secondary infertility, and have previously had children 
- Focuses purely on women experiencing infertility as part of a wider medical condition 
 
Figure 1.  Flowchart of Search Results 
 
 
 
 
 
 
 
 
 
 
 
EBSCO host search 
(PsycINFO & 
CINAHL)  
- 571 results 
OVID search (Medline 
and Embase)  
- 3684 results 
Title review 
-85 selected 
(excluding within 
search duplicates) 
Title review 
-118 selected 
(excluding within 
search duplicates) 
Abstract review 
- 28 selected (excluding between 
search duplicates) 
 
Full text review 
- 8 selected 
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Table 1.  Selected study details and quality ratings 
Study (Year)  Country Method Participants 
 
 
Themes 
Bergart  
(2000)  
 
 
 
 
America Grounded 
theory 
- 10 women 
- 32 to 45 years old 
-After unsuccessful IVF treatment 
(ended at least 6 months earlier after at 
least 3 years treatment) 
 
Entering the role of an ‘infertility’ patient 
Physical impact of treatment 
Emotional impact of treatment 
Reactions to extended, unsuccessful treatment 
The impact of pregnancy loss 
The impact on other areas of life 
Value of emotional support from other 
infertile women 
Stance of the physician 
Reaching limits 
Decision to stop treatment 
 
Gonzalez  
(2000) 
 
 
America Thematic 
analysis 
- 25 women 
- 20 to 40 years old 
-All had sought fertility treatment 
Failure to fulfil a prescribed societal norm 
Assault on personal identity 
Mourning 
Transformation 
Restitution 
 
Peters   
(2003) 
 
 
Australia Thematic 
analysis 
- 6 women  
- mid 30s to early 40s 
-Received IVF for 2 to 3 years 
- Some participants had adopted or 
fostered 
Keeping secrets 
Why Me? 
Trying different avenues 
Getting it wrong 
Being let down 
 
Johansson and Sweden Phenomenology - 8 women Childlessness is a central issue in life 
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Berg (2005) 
 
 
 
- 34 to 41 years 
-2 years after end of IVF treatment 
-Infertile for at least 7 years 
- One participant fostered and awaiting 
adoption 
IVF is an important and positive part of life 
Contact with other people is not an important 
issue 
Hope of achieving pregnancy still exists 
Attempts to identify other central issues in 
life 
 
Peddie, van 
Teijlingen and 
Bhattacharya  
(2005) 
 
 
 
Scotland Thematic 
analysis 
- 25 women 
- Mean(SD) age 37 years(4.5) 
- 3 to 24 months after end of IVF 
treatment. 
- Some had adopted 
Difficulty with acceptance of infertility 
Stress associated with IVF 
Unrealistic expectations of treatment 
Pressure from media and society 
Insufficient information specific to the 
individual 
Social and professional opportunity costs 
Physical and emotional pressure exerted on a 
couple’s relationship 
Information provision and communication 
skills during final consultation 
Lack of continued support from the IVF unit 
 
Wirtberg et al. 
(2007) 
 
 
Sweden ‘Qualitative 
approach’  
- 14 women 
- 48 to 60 years old 
-20 years after end of infertility 
treatment 
Looking back at time as infertility patient  
Other means of parenting 
Long term effects of infertility and 
childlessness 
Effects on sexuality 
Development of non-parent life style 
Life as a caring activity 
And some did not turn the corner 
The silent story 
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McCarthy  
(2008) 
 
 
 
America Phenomenology - 22 women 
- 33 to 48 years old 
- Average 3.9 years after end of 
treatment 
- Some had adopted 
Revisioning self in life’s context 
Revisioning the world in life’s context 
Experiencing isolation: A sister set apart 
Permanent presence 
Choosing to go on 
Creating a different kind of life 
 
Volgsten, 
Skoog 
Svanberg and 
Olsson 
(2010) 
Sweden Content analysis - 10 women (and 9 men, not included in 
current review) 
- 35 to 43 years 
- At least 3 years after IVF treatment  
- Some in process of adopting 
Putting up a shield 
Late realization of the need of professional 
support 
Affected partner relationship 
Frustrated  at ending of IVF 
Unanswered questions after ending IVF 
Feeling excluded and lacking understanding 
Loss of future life goals 
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Quality of data 
Assessing the quality of qualitative research has been debated for many years 
(Holloway and Wheeler, 1996; Perakyla, 1997; Popay & Rogers 1998). One area of 
controversy is how best to appraise the quality of qualitative research (Spencer et al., 2003). 
For example, Dixon-Woods, Shaw, Agarwal & Smith. (2004) note that it is difficult to 
identify what may be considered as a fatal methodological flaw in qualitative studies due to 
differences in qualitative research designs.  
In order to develop a practical guide for assessing the quality of qualitative studies 
which is firmly grounded in qualitative research, Walsh and Downe (2006) reviewed eight 
previous frameworks for qualitative research, pulled them together and eliminated non-
essential criteria. The quality of studies included in the current review were assessed using a 
scoring system based on Walsh and Downe’s resulting framework which includes essential 
criteria covering the following stages; scope and purpose, design, sampling strategy, analysis, 
interpretation, reflexivity, ethical dimensions, and relevance and transferability (see 
Appendix 1.2 for scoring criteria). Each study was compared to a total of 29 criteria, with 
each being marked as present or absent to determine a profile of strengths and weaknesses. 
Criteria were marked as absent if they were not met or if it was not possible to determine 
from the information given. As it is difficult to define fundamental flaws in qualitative 
research, the framework was used to indicate the quality of studies rather than to exclude 
those failing to meet a predetermined threshold. All papers were second rated by an 
independent reviewer and any disagreements were resolved through discussion.  
The scope and purpose of all the included studies was described well, with all 
researchers making a clear statement of their focus, rationale and research aims. All studies 
were contextualised by existing literature.  
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Studies generally had good designs that were appropriate to the research questions 
and all authors provided a rationale for their method of data collection. Samples and sampling 
methods were described for all studies and, with the exception of Gonzalez (2000) and Peters 
(2003) a justification was provided. In contrast, the level of background information about 
participants, in terms of age, fertility treatment and whether they had adopted children, varied 
across studies. 
All studies provided an appropriate analytic approach, however specific quality 
criterion for analysis varied across studies. Half of the studies involved a second researcher in 
data analysis (Gonzalez, 2000, Peddie et al., 2005, Volgsten et al, 2010; Wirtberg et al., 
2007). A strength of Gonzalez’ (2000) study was that participants were also involved in the 
analysis. Only Gonzalez (2000) and McCarthy (2008) discussed having reached a point of 
data saturation. 
Study contexts were described, however only Peddie et al. (2005) and Volgsten et al. 
(2010) explicitly accounted for the socio-cultural setting and for infertility being a sensitive 
issue to discuss in their interpretations. In contrast, all researchers considered the overall 
context of remaining infertile despite having had infertility treatment in their interpretations. 
All of the researchers used interview data to support their interpretations, however there were 
no audit trials of the processes that led to their interpretations. Only McCarthy (2008) and 
Peddie et al. (2005) demonstrated researcher reflexivity in their study report. 
Explicit reference to ethical dimensions also varied across studies. A weakness of 
Gonzalez’ (2000) study was that there was no indication of whether ethical approval had been 
granted. Whereas most (with the exception of Bergart, 2000; McCarthy, 2008; Wirtberg et 
al., 2007) made reference to confidentiality and anonymity, only Gonzalez (2000), McCarthy 
(2008) and Volgsten et al.(2010) discussed the process of participant consent.  
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Finally, evidence of relevance and transferability of findings was provided in all 
studies and findings were discussed in the context of previous theory or literature. 
Acknowledgement of study limitations was generally provided, with only Bergart (2000), 
Gonzalez (2000) and Johansson and Berg (2005) failing to discuss such weaknesses. Three 
studies gave no suggestions for further research directions (Bergart, 2000; McCarthy, 2008; 
Volgsten et al. 2010).  
 
Method of synthesis 
The term meta-synthesis is commonly used to describe a number of methods 
developed to synthesise qualitative research (Barnett-Page & Thomas, 2009). These methods 
are interpretative in nature, aiming to further develop understanding and explanations of 
phenomena, generating new insights and understanding (Walsh & Downe, 2005).  
Meta-ethnography (Noblit & Hare, 1988), one type of meta-synthesis, was used in the 
current review. This involves a seven stage process proposed by Noblit and Hare (1988) and 
described further by Atkins et al. (2008). The seven stages are outlined in Table 2. Meta-
ethnography was selected as it allows the synthesis of studies employing a range of 
qualitative methods (Ring, Ritchie, Mandara & Jepson, 2011). Themes were compared across 
studies in order to determine the most dominant factors. This allowed for the most prominent 
themes to be explored in order to develop a holistic understanding of women’s experiences. 
Participants’ views and beliefs as elicited from quotations in the published studies, and the 
original author’s interpretations of these, were synthesised. This led to the current author’s 
interpretation of the women’s experiences as a whole.  
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Table 2.  Stages of meta-ethnography 
 
 Stages 
 
Description 
1) Getting started Determine research question 
2) Deciding what is relevant to the 
initial interest 
Defining the focus of the synthesis 
Locating relevant studies 
Making decisions about inclusion 
Quality assessment 
3) Reading the studies Become familiar with the content and 
detail 
Begin to extract ‘metaphors’ or emerging 
themes 
4) Determining how studies are related Create a list of themes and metaphors 
Juxtaposition of above 
Determine how themes are related 
Reduce themes to relevant categories 
5) Translating studies into one another Arrange papers chronologically 
Compare paper 1 with paper 2, and the 
synthesis of these papers with paper 3 
and so on 
6) Synthesising translations Third order interpretation leading to a 
line of argument synthesis 
7) Expressing the synthesis Presentation of results 
Publication of findings 
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Results 
As recommended by Noblit and Hare (1988), study themes were listed in chronological 
order to determine relationships between study findings and to compare identified themes. Study 
themes are outlined in Table 1. This process elicited the following six key factors in women’s 
experience of infertility: (i) feeling different, (ii) compromised female identity, (iii) maintaining 
hope, (iv) sensitivity of professional support, (v) developing a new life, and (vi) affected intimate 
relationships. Highlighting the most prominent elements identified in the synthesis, each theme will 
be discussed in turn. Quotations from study participants appear in italics, quotations from study 
authors do not.  
Feeling different  
Women in all studies reported a sense of feeling different. The participants described a 
general feeling that they did not fit in with their peers, attributing this to not sharing experiences 
with them. One participant said: 
‘I hated ... not blending with everybody and being the couple that everyone felt sorry for 
... It’s like a sorority that I’m never going to be a part of’ (McCarthy, 2008) 
This quotation highlights women’s feelings of being an outsider. It also suggests a desire to feel part 
of social group and a sense of loss that this is not the case. 
Women also experienced difficulties being around others who had children or were pregnant. 
Gonzalez (2000) for example, notes that women in his study reported feelings of envy towards 
other women. Some reported that such difficulties resulted in them withdrawing from social 
situations, as in the following quotation. 
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 ‘I didn’t feel sociable, but deep down I missed the social interaction. I suppose I was 
afraid that someone would appear with a baby or to say that they were pregnant, and I, 
just couldn’t cope with that.’ (Peddie et al., 2005) 
It seems that it was sometimes easier for women to miss out on social situations than to manage 
their feelings of being different and the pain of seeing others with children. 
The ongoing impact of feeling different from peers was demonstrated in Wirtberg et al.’s 
(2007) study, which showed that ‘the experience of isolation had persisted for half of the women 
and re-emerged when their peer group was reaching the stage of grandparenthood’. Feelings of 
social isolation therefore seem not only to be long lasting, but also to be particularly pertinent at 
certain life stages. One lady said: 
‘I found myself making excuses for not visiting, or taking a trip to the bathroom when 
the latest photos of grandchildren were passed around. I really had to get a grip on 
myself and break that; suddenly it was like turning the clock back twenty years.’ 
(Wirtberg et al., 2007) 
Peers becoming grandparents echoed the women’s previous experience of their social group 
becoming mothers. Social avoidance again became a coping strategy in this later life stage.  
Feeling different from others also resulted in women feeling stigmatised or anticipating that 
they would be. Peters (2003) stated that ‘participants acknowledge an attached stigma to aspects of 
infertility and assisted reproductive treatment’. He goes on to report that some women ‘feared the 
cultural and religious implications of being infertile and seeking assisted reproductive treatment. 
Others wished to avoid being the target of gossip.’ Women therefore seemed to be aware that their 
situation differed from social expectations and, as a result, often opted not to discuss their infertility 
with others, fearing a negative outcome. One participant said: 
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 “It was a hidden burden. I kept it a secret. I was ashamed. I didn’t want anyone to 
know.’ (Gonzalez, 2000) 
Further, Peters (2003) stated that ‘the general public remained relatively uninformed, and 
therefore ill equipped to deal with issues surrounding it’. This factor was reported to further 
influence the sense of isolation these women experienced. Participants talked about friends and 
family not understanding and being insensitive or hurtful. Such experiences are apparent in the 
quote below. 
 ‘Some [friendships] didn’t survive ... the infertility ... One in particular was very, 
very painful, because it ... started ending shortly after I lost the baby, and this had 
been a ten year relationship ... [S]he got pregnant about three months after I had 
lost the baby ... But then when she got pregnant, it became, ‘Oh, I can’t believe ... 
how I’m feeling. I have to go through this shit. Men don’t know how lucky they 
are’. And ... I said ... I can’t listen. I can’t listen to your complaint about being 
pregnant. I-I can’t. I just can’t’. (Bergart, 2000)  
A final concern about being different from others was that of being alone in old age. 
McCarthy (2008) reported that ‘The lack of a family introduces an ambiguity about what to 
expect as one ages and contributed to a concern about being alone’. Women reported having 
concerns about who would look after them in later life, continuing the family, and passing on 
inheritance and family heirlooms. 
Feeling different was described by women in all studies, including those where some 
participants had adopted children, suggesting that becoming a parent through this means did 
not overcome feelings of difference. 
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Maintaining hope 
Women in all studies reported that they maintained a hopeful stance through infertility 
treatment and beyond. They explained that their menstrual cycle brought a monthly pattern of 
hope for pregnancy followed by despair at menstruation.  Johansson and Berg (2005) 
described how this was true during IVF treatment, where ‘The fertilized egg is experienced as 
a child and when menstruation occurs it feels like a miscarriage’. Explaining this experience, 
one woman reported: 
‘You’re so on the edge; you’re trying to get pregnant. Every month it’s a roller 
coaster of emotions waiting, waiting, waiting, - and then the big disappointment’ 
(Bergart, 2000) 
Medical staff appeared to play a role in maintaining this hope. For example, Bergart 
(2000) found ‘The doctors of seven of the ten women maintained a hopeful stance, not 
indicating that treatment might fail’ and stated ‘Several women saw this stance as a “carrot”, 
feeling that their doctors were “dangling” hope in front of them.’ One woman in Peters 
(2003) study reported: 
‘The staff in the clinic were sort of too positive I think. They sort of made you feel 
like this is really going to happen. They weren’t negative at all. They made you 
feel real sure of yourself. You’d hit rock bottom when it wasn’t successful’  
This woman’s belief that staff were too positive echoes that of others who felt they should be 
given all information, including the negative, to ensure they are fully informed. The optimism 
of medical staff influenced the women’s beliefs about treatment success which in turn had an 
impact on their feelings when treatment was not successful; experiencing it as a letdown or 
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failure. Staff optimism and lack of accurate information therefore contribute to maintaining 
hope and to feeling a sense of despair at menstruation.  
Women also, however, reported that they held onto the possibility of pregnancy many 
years after treatment finished, emphasising that as long as they menstruated there was still a 
chance they could have a child.  One participant stated: 
 ‘I do not think one wants to hear that it is definite before one reaches menopause, 
then one has to accept it. (Johansson and Berg, 2000) 
This quotation illustrates that hope remains until menopause makes it explicit that the women 
cannot become pregnant. This was evident too in women followed up longer term, with 
Wirtberg et al. (2007) reporting ‘Still some of the women, who thought they had worked 
through the issue, surprised themselves when they reached menopause and reacted with 
depression and grief.’ Hope therefore, although perhaps not consciously so, seems to remain 
present for these women, who finally grieve their fertility when they reach menopause.  
Johansson & Berg (2000) reported that ‘Hope is experienced as immensely important, 
being the driving force that enables life to continue’. On the other hand Volgsten et al. (2010) 
note that ‘it was difficult not knowing how to handle grief’. Hope therefore seems to be 
employed as a coping mechanism which allows these women to avoid fully experiencing the 
loss of their fertility. Although useful in the short term, this delayed the grief reaction and 
maintained a focus on fertility throughout these women’s lives. 
Infertility as a central life focus indeed came across in many of the studies. As Peters 
(2003) reports ‘participants had a major change in their focus to life with everything now 
revolving around getting pregnant.’ One woman stated: 
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‘[Y]our whole life becomes like your menstrual cycle ... [E]verything else about 
your life is very peripheral, and ... that’s sort of like how you measure things.’ 
(Bergart, 2000) 
Not only does maintained hope of becoming a mother become a focus, it therefore also 
seems to detract attention from other areas. As infertility ‘takes up a large part of their 
existence’ (Johansson & Berg, 2005), the women do not have the same resources for other 
areas as they may otherwise have had. One participant stated:  
‘I just felt like my life was in limbo for so long ... I was stuck in a job I didn’t like. 
I was doing this treatment ... I put the rest of my life in limbo and did this. And this 
is what I did for three and a half years – went to doctors, had treatment, waited 
for my period ... It’s ... almost like the freeze frame [in a] video or something.’ 
(Bergart, 2000) 
Treatment therefore became a central aspect of life whereas other areas became less 
important, frozen to be resumed once pregnancy is achieved. Again this indicates a hope that 
pregnancy will be achieved. 
When pregnancy is not achieved, however, women continue to focus on the hope of 
future pregnancy. Wirtberg et al. (2007) reported ‘Another felt very strongly that the desire 
for a child still dominated her life and she would never get over it. To live a life of trying to 
conceive a child had become her dominant state, and now when her biological clock had 
finally ‘tolled’, she was at loss at how to find meaning for herself in life’. Again, focusing on 
the hope of pregnancy had detracted from reconsidering her life without children, which was 
forced upon her at menopause. In this study of the longer term experience of infertility 
Wirtberg et al. (2007) reported that ‘The interviewer found herself often being transported 
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back in time, listening to a story that was a very living and dynamic part of the present, 
everyday life of these women.’ Although many years after treatment had finished, infertility 
remained a central focus which impacted their daily lives. 
Compromised female identity 
The majority of studies discussed an altered sense of self, largely in terms of a 
compromised female identity (Bergart, 2000; Gonzalez, 2000; McCarthy, 2008; Peters, 2003; 
Volgsten, et al. 2010; Wirtberg et al., 2007). Participants felt that a woman’s role was to 
become a mother and that they therefore should be able to have a child. Gonzalez (2000) 
reported that ‘This failure to fulfil a societal norm was described as an assault on their 
personal identity, often in terms of threats to self-concept and body image. One lady described 
this as: 
‘It was almost as if you cannot run with your legs – you have two legs but you 
cannot run with them’ (Gonzalez, 2000) 
This alludes to a perceived sense of failure of their bodies. As women they felt they should be 
designed to reproduce, however they were unable to do so. This often affected their self-
esteem and ‘Many women described a sense of personal failure and worthlessness’ (Bergart, 
2000). They felt that they were not complete as women, and were therefore less worthy than 
others. One woman reported: 
‘there was something wrong with me I wasn’t a proper woman, I didn’t 
understand why my husband wanted to stay with me ... because I couldn’t give 
him what he wanted ... I felt worthless ... I thought I couldn’t do anything’ 
(Volgsten et al., 2010) 
29 
 
It is apparent that a compromised sense of self as women in turn affected beliefs about 
their worth to others. The women appeared to place a strong emphasis on child bearing in 
their judgement of self-worth, seeing this as a defining characteristic of a woman. This is 
echoed in the following quotation: 
‘It’s like you thought you were this solid chocolate bunny and you’re not. You’re 
the hollow chocolate bunny, which is the less expensive version, not quite as good 
and not what everybody really wanted at Easter.’ (McCarthy, 2008) 
This reveals an expectation that one will be able to have children and the challenge to one’s 
identity when you realise this is not so. Not only did this cause a readjustment of the women’s 
sense of self, but also led to a compromised one, which saw the self as inferior to others, 
unworthy of affection and as incomplete. 
Sensitivity of professional support  
Women in half of the studies reported that they were not wholly satisfied with the support 
provided for them by professionals during infertility treatment (Bergart, 2000; Peddie et al. 
2005; Peters, 2003; Volgsten, et al., 2010). This was largely in terms of ‘“mechanical” and 
impersonal aspects of the treatment, which tended to make them feel like machines or body 
parts rather than people’ (Bergart, 2000). One woman described her experience as: 
 ‘[S]ometimes you’re shuffled in and out so quickly it doesn’t seem that they 
realize how important this is. This isn’t a bunion you’re having removed. This is 
something that is affecting your life, day in and day out. And you want more 
personalized care. You don’t wanna feel like you’re ... that 3:15-in-the-after-
noon-appointment, whatever-your-name-is.’ (Bergart, 2000) 
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This illustrates that women felt they were not treated as individuals and that the sensitive 
nature of the treatment was not taken into account.  
A particularly salient time for many of the women was the ending of treatment. 
Bergart (2000) reported that ‘Four of the ten women spoke positively of having doctors who 
helped them and their husbands to look at low probabilities of success, or to set limits of their 
treatment’ (Bergart, 2000). The time given to discuss the likelihood of success and the ending 
of treatment, however, was rarely reported. The majority of women’s experiences were 
captured by Volgsten et al. (2010) statement that ‘Treatments were described as being too 
forced and the ending often being abrupt.’ Peddie et al. (2005) also explained that 
‘Respondents reported a sense of being ‘unprepared’ for the major step of ‘decision-making’ 
and felt that an additional appointment/s to discuss the effects of ending treatment would have 
been beneficial.’  Women expressed a desire for more time to be taken to discuss ending 
treatment and the impact that this may have on them.  
Support in the decision making process was described as lacking and ‘The need for 
continued support from the Unit some time after ending treatment appeared to be universal’ 
(Peddie et al., 2005). Many women had no further contact with the service after they decided 
to end treatment and professionals made no acknowledgement of what the women had been 
through, or the lasting impact this may have. One woman explained: 
 ‘[W]hen I went in there for the final conference, [the doctor was] just sitting 
there talking to me about the medical aspects of it, but never once said, ‘Well, 
how are you? ... How do you feel about this?’... And I was just floored by it, 
because ... [she] had been so good throughout everything ... [so] supportive, but 
then right at the end it was like, as far as any psychological support ... nothing ... I 
was just so hurt by [her way of] speaking to me.’ (Bergart, 2000) 
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This suggests that women felt they were let down by those they had placed their trust in and 
that there is a need for a more holistic approach to treatment, taking into account the 
emotional aspects as well as the medical. Women in some studies felt that additional input in 
the form of counselling may be beneficial: 
 ‘To me communication is everything, and as for making the final decision to end 
treatment, enlisting the help of a counsellor at this stage would be a more 
sensitive way of going about it.’ (Peddie et al, 2005) 
A failure to take adequate account of individual and emotional factors left women feeling 
unsupported and on their own, particularly at the end of treatment. 
The above reports differ from those described by Johansson and Berg (2005) who 
state that: ‘The women are pleased and proud of being able to participate in IVF treatments. 
The treatment has given them a stronger feeling of self-esteem.’ The lead researcher and 
interviewer for this study, however, was involved in the care and treatment of infertile 
couples. Hence, participants may have felt less able to describe negative aspects of their IVF 
experience due to social desirability. 
The studies also came from a range of Western countries and cover a range of 
healthcare systems, including public services in Scotland and Sweden, mixed public and 
private systems in Australia and private care in America. Further, despite some women 
having access to publicly funded treatment they opted for private care. Women’s experiences 
are likely to have been influenced by the particular healthcare systems they used. For 
example, in Peddie et al.’s (2000) study, they noted that two thirds of people opt for private 
fertility treatment and that financial restraints influenced the women’s decision to end 
treatment. In such instances it may be that endings felt abrupt as no further input could be 
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offered when the couple no longer had resources to pay for this. Participant’s more positive 
experiences reported in Johansson & Berg’s (2005) Swedish study may reflect their being 
more scope to offer support beyond active treatment in a public setting. Given the variations 
in sources of funding both within and between studies, however, it was difficult to fully 
interpret the impact of healthcare systems on the women’s experience of care. 
Developing a new life  
Contrary to the theme of maintaining hope, which suggests that women hold onto the 
chance of pregnancy throughout their adult lives and that this becomes a central life focus, 
studies also found the women attempted to develop an alternative life to that of parenthood 
(Bergart, 2000; Gonzalez, 2000; Johansson & Berg, 2005; McCarthy, 2008; Peddie et al., 
2005; Wirtberg et al., 2007). As McCarthy (2008) reports ‘The women described very active 
awareness of taking stock, letting go, and doing whatever it took to create a new space to 
move on into.’ Women made a decision to move on to a life that does not involve having 
children and tried to identify a different life focus. One woman explained: 
 ‘I am always going to regret that we can’t have a child, but you have to accept 
what you’ve got rather than what you haven’t. You have to make alternative plans 
and they don’t include children.’ (Peddie et al., 2005) 
This suggests that, although a child is still desired, a point of acceptance was reached when 
other life opportunities could be realised. The alternative plans made varied, however 
Wirtberg et al. (2007) reported that ‘The most-told story about making meaning in life and 
coming to terms with childlessness was that of caring for somebody – most often a child’. 
Again this contrasts the notion of avoiding situations in which there are children discussed 
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under the feeling different theme, and Wirtberg et al. (2007) note this is a shift in the women’s 
behaviour.  
 ‘The loss of parenthood, of not having a family including a child, was described as a 
different life situation; but at the same time, a life situation with more freedom’ (Volgsten et 
al.2010). This notion of seeing a life without children as being a different life that created 
further opportunities was indeed identified in other studies. For example, a woman in 
Johansson and Berg’s (2005) study reported: 
‘One can see how very positive it is to not have children. One can travel, I can go 
out in my car and drive wherever I want and whenever I like.’ (Johansson and 
Berg, 2005) 
Women identified that there were more options for them in terms of work, travel and hobbies 
as they were less restricted without children. Identifying such lifestyle opportunities and 
finding other ways to fulfil a caring role appeared to allow the women to move beyond 
focusing on their loss and towards developing a new life. As Wirtberg et al. (2007) report 
‘through consciously trying to focus on one’s good fortune rather than one’s misfortune, 
several had found a sense of meaning.’ These women therefore appeared to develop 
meaningful lives after an active decision to focus on areas other than becoming a parent. 
Despite this, it was not found that developing a new life resulted in full acceptance of 
infertility. For example, Gonzalez reported ‘Despite achievement of a realistic perspective, 
the inability to conceive and bear a child continued to be a significant factor in the definition 
of self.’ (Gonzalez, 2000). One participant describes this saying: 
‘Even though that old nagging thought is still back there; it is not the same. So, I 
don’t think it’s resolved, but I think it’s different.’  
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Affected intimate relationships 
Four studies reported women experiencing difficult relationships with partners or sexual 
problems (Bergart, 2000; Peddie et al., 2005; Volgsten et al., 2010; Wirtberg et al., 2007). 
Volgsten et al. (2010) stated ‘Some men and women described how the relationship with their 
partner had been strengthened in a critical situation. Other men and women experienced strain 
in the relationship and temporary separations after ending IVF’. The studies gave various 
reasons for the strain on couples, emphasising financial pressures, poor communication, self-
perceptions about being inadequate as women, and the competing demands of treatment and 
other aspects of life. Again relationship pressures may partly be influenced by the health care 
system the couple are using and the related financial pressure this brings. One woman in 
Peddie et al.’s (2005) study explained the financial strain of treatment: 
 ‘not that we grudged the money; I mean you can’t put a price on a child, but it 
added to the stress of it all.’ (Peddie et al., 2005) 
Studies also reported a lack of lust and enjoyment in sexual life. 
‘[O]ur sexual relationship really got strained ... [We] didn’t make love for a year, 
we had sex. We had this copulation where I was making a baby, and he was 
indulging me. (Bergart, 2000) 
It seems that being infertile and going through infertility treatment changed sexual 
experiences for these women, with the hope for pregnancy being dominant. One woman 
explained that ‘the enjoyment just ebbed away’ (Wirtberg et al., 2007), suggesting that 
additional pressure took the pleasure away from sexual relationships. Wirtberg et al. (2007) 
found that ‘as many as nine reported that their sexual life and sexual desire was lost forever’ 
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suggesting that this was a problem for couples long beyond infertility treatment. The women 
in this study also felt they would have benefited from counselling in this area.   
Discussion 
This review synthesised recent qualitative data about women’s experiences of 
infertility in order to facilitate greater understanding of such experiences in a Western 
context. Women reported that being unable to have children made them feel different to their 
peers and led to a sense of isolation.  Withdrawal from social contexts where there was a risk 
of being judged by others, or of being in the company of those who highlight a sense of 
difference, has been proposed by Goffman (1963) to be a means of coping with stigma. 
Women also reported an altered sense of self, feeling that they were not complete or adequate 
as women. Infertility as a challenge to women’s core female identity has also been identified 
in previous literature (Cousineau and Domar, 2007). The above themes led to additional strain 
on couples, with intimacy becoming less enjoyable and solely focused on achieving 
pregnancy. Again this is in keeping with literature which has found infertility to affect 
relationships and sexual satisfaction (Bergart, 2000).  
The expectation that women will become mothers is reflected in Carter and 
McGoldrick’s (1989) family lifecycle model. The women’s experience of stigma suggests 
that cultural expectations and Western pronatalist ideologies remain focused on traditional 
family patterns, despite many families no longer following the stages set out in Carter and 
McGoldrick’s model (Ulrich & Weatherall, 2000). Further, the women’s feelings of being 
different became particularly pertinent at certain life stages suggesting that social norms 
continue to follow set patterns of childbearing. The family lifecycle model therefore appears 
to remain useful in understanding the experiences of infertile women.  
36 
 
Maintaining hope throughout treatment and beyond was described by many women, 
with menstruation bringing disappointment. This supports Glazer and Cooper (1988) who 
proposed that infertility is associated with recurrent losses rather than representing a single 
life crisis. As hope for pregnancy persisted throughout most of their adult lives, the desire to 
become a mother became a central focus. This seemed to have an adverse effect on other 
areas of life which were effectively put on hold. Contrary to Eugster & Vingerhoets (1999) 
and Weaver (1997), who proposed that life grief is a central factor for infertile women, these 
women’s accounts suggested that losses were responded to by focusing attention on hope for 
a positive future outcome, allowing grief to be delayed.  
Although women described active attempts to find meaning in other areas of life, 
maintaining hope for pregnancy and delaying grieving for their fertility appeared to prevent 
full acceptance of their infertility. It also seems that some women felt they were not offered 
the opportunity, or did not feel comfortable enough, to discuss the emotional impact of 
infertility and its treatment with professionals. More sensitive care and a more holistic ending 
to treatment may have provided greater opportunities to process their emotional reactions.   
Diversity in the quality of included studies may, however, have impacted on findings. 
As only half of the studies employed second raters in the analysis stage, study interpretations 
may be affected by researcher’s own assumptions and values. Some differences between 
studies therefore may reflect individual interpretations rather than participants reporting 
different experiences. Further, only two studies mentioned achieving data saturation, 
therefore some themes may have been more dominant in the synthesis had larger sample sizes 
been recruited and data saturation reached. The context in which the data was collected must 
also be considered, yet was rarely mentioned in study reports. Study findings may therefore 
be a product of the healthcare systems and specific contexts they took place in. For example, 
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the women’s experiences may have been affected by how well services are set up to offer 
emotional support and whether such support is available once active treatment, and 
potentially payment for this, have ceased. 
Limitations 
There are a number of limitations to the current review which should be addressed. 
Firstly, word limit requirements of journals may have meant that some methodological 
information was not provided despite it being considered in the research project. Profiles of 
strengths and weaknesses may not therefore accurately reflect the research project itself, and 
rather reflect quality of the written report within such restraints (Sandelowski and Barroso, 
2002).  
Secondly, there may be a sampling bias in these studies as women may have been 
more motivated to engage in the research if they had particularly strong feelings about their 
experience of infertility. All women included had sought infertility treatment and may differ 
from those who do not pursue this route. The voices of those unable to pay for infertility 
treatment in countries where this is required were also missing.  In order to ensure a certain 
level of quality, only published studies were included in the current review. However, there 
may be a publication bias meaning other relevant studies may have been excluded. Finally, 
controversy exists over whether the integration of studies using a diverse range of 
methodological approaches is appropriate. While a number of strong themes did emerge from 
the studies, there were a number of subtleties that were difficult to capture.  
The samples of women included in the studies tended to be from across a wide age 
range. Although this is beneficial as it allows for accounts of those initially coming to terms 
with their infertility and those looking back over their life experiences, specific experiences 
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associated with different stages may have been missed. Future studies should therefore aim to 
examine the experience of infertility at distinct life stages and take account of the particular 
health conditions that may be the cause of the women’s infertility. 
Implications 
The current review suggests that care should be taken to consider the individual and 
emotional aspects of infertility as well as the medical. Staff need to remain alert to the 
sensitive nature of infertility in their consultations with women, and training for staff on the 
psychosocial impact to infertility, as well as skills development in normalising, active 
listening and containment, would help them to respond appropriately. Time should be given 
to assess and discuss how the women are coping and the wider impact of infertility on their 
lives. Follow-up appointments should also be offered after the end of treatment to provide 
women with support regarding the longer-term impact of their infertility. Given the challenge 
that feelings of difference brings to women’s sense of self, the provision of social support 
from other infertile women may be beneficial.  
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Lay summary 
Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome is a medical condition where women 
are unable to have periods, sexual intercourse, or to have a child. Previous research has 
shown that MRKH has an emotional, as well as physical, impact.  The unique experience of 
MRKH for young women as they become adults, however, has not been investigated. The 
aim of the current study was to explore young women’s experiences of having MRKH in 
terms of social and emotional challenges, and the impact of MRKH on their identities. Five 
women aged 18 to 22 years old were interviewed and asked about their experiences of having 
MRKH. The results of the interviews found four main themes which explained their 
experience of MRKH: hindering independence, a sensitivity to difference, managing intimacy 
and managing threat to identity. These themes showed how difficult it is for young women to 
discuss their condition with others and that having MRKH affects their confidence and female 
identity. This study offers new insights into the significant social impact of MRKH as young 
women become adults and highlights the need for professionals to address this. Running 
support groups for women of similar ages is also advised.  
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Abstract  
Background: MRKH is a congenital condition which renders women unable to menstruate, 
carry a child, or have sexual intercourse (Edmonds, 2000). However, there is a scarcity of 
research regarding the psychological impact of the condition. Diagnosis is made in mid to late 
adolescence, a time where social relationships and identity are salient, hence there may be 
specific challenges at this point and through the transition to adulthood. 
Aims: The study aimed to explore the impact of MRKH on young women. 
Methods: Five women (aged 18 to 22) diagnosed within the past five years took part in a non-
directive semi-structured interview. Transcripts were analysed using Interpretative 
Phenomenological Analysis.  
Results: Four themes were identified; hindering independence, a sensitivity to difference, 
managing intimacy and managing threat to identity. The personal and sensitive nature of 
MRKH had a significant social impact for the young women’s developing identity, 
autonomy, and negotiation of peer and sexual relationships. Fear of being stigmatised caused 
them to manage their presentation to others in order to minimise the impact of their diagnosis.  
Conclusions: The study offered a unique insight into the social challenges of MRKH in the 
transition to adulthood. Implications for services and future research directions are indicated. 
  
Key words: MRKH; late adolescence; lived experience; identity; social relationships 
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Introduction 
Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome is a congenital condition 
where, although women have normally functioning ovaries, the vagina and uterus do not 
develop (Edmonds, 2000). The condition, which occurs in around 1 in 5000 women, causes 
them to be unable to menstruate, participate in sexual intercourse and carry children (Bean, 
Mazur & Robinson, 2009; Edmonds 2003). Women typically present to services when 
menstruation has not begun despite normal development of secondary sexual characteristics 
(Aittomaki, Eroila & Kajanoja 2001; Mungadi, Ahmad, Yunusa, Agwu & Ismail, 2010).  
Historically treatment and research regarding MRKH have largely focused on 
physical aspects and on medical procedures to create a neovagina (Bean et al., 2009). Holt 
and Slade (2003) found women’s experience of such services to be that there was a scarcity 
of accessible and appropriate information, and that treatment felt impersonal. There is now, 
however, increasing recognition of the need to support women with the psychological impact 
of MRKH (Edmonds, 2003, Hughes, Nihoul-Fekete & Thomas, 2007). In keeping with this, 
Brain et al. (2010) proposed that care should be provided by a multidisciplinary team, 
involving psychologists as well as medical professionals. The development of more holistic 
services requires a deeper understanding of the experiences of women with MRKH to ensure 
that services target areas of importance and provide sensitive support to service users. 
In a review of research studies, Bean et al (2009) reported a range of reactions to a 
diagnosis of MRKH including depression, shock, fear of partner rejection, and feeling 
different. Women who were diagnosed with MRKH ten years previously indicated scores for 
mental health disorders that fell between normal and psychiatric ranges (Heller-Boersma, 
Schmidt & Edmonds, 2009a). The inability to carry a child has been suggested to be one of 
the most distressing effects of MRKH, and therefore may have a strong impact on women’s 
wellbeing (Bean et al., 2009; Kimberley, Hutson, Southwell & Grover, 2011). Carrying a 
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child is typically thought to be a key life role for women and the inability to do so has been 
found to have the potential to challenge their self-esteem and gender identity, and to lead to 
jealousy and a sense of isolation around peers who have children (Holt & Slade, 2003, Bean 
et al., 2009).   
Although a cognitive behavioural model for MRKH has been developed by Heller-
Boersma, Schmidt & Edmonds (2007, 2009b) this was developed on the basis of a 
quantitative study comparing women with and without MRKH on a number of questionnaire 
measures of psychological distress and on past quantitative research. Without a qualitative 
exploration into their experiences, there is limited insight into the unique challenges that 
MRKH brings, hence the essence of women’s experiences may not be captured.  
A recent review of qualitative studies investigating women’s experiences of infertility 
identified the following themes from the literature: feeling different, compromised female 
identity, maintaining hope, sensitivity of professional support, developing a new life and 
affected intimate relationships (Espie, this volume). However, a downfall of this literature 
was that the study samples represented a broad age range. Therefore identified themes were 
likely to reflect only the commonalities across the age span. This prevented the accounts of 
the particular experiences of women at different life stages from emerging. Further, a need to 
explore the distinct experiences of specific populations where infertility is an issue was 
indicated.  
In the only qualitative study of women’s experiences of MRKH, Holt and Slade 
(2003) found that the role of time came out as a theme for women diagnosed between two and 
22 years previously. It is unsurprising that women’s views will change as they adjust or adapt 
to the condition, but this highlights that one theoretical model is unlikely to explain women’s 
experiences at different stages of their lives. There is therefore a need to study the specific 
experiences of MRKH at different time points in order to understand the subtleties of its 
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interactions with various life stages. Given the unfolding nature of key developmental tasks 
of different life stages, the aspects of MRKH which cause the most distress may change and 
fluctuate over time.  
Diagnosis of MRKH typically occurs in mid to late adolescence, (Aittomaki et al. 
2001; Mungadi et al. 2010) hence initial adjustment will likely take place during this 
transitional stage. This is an important life stage for identity formation and is associated with 
physical, cognitive and social changes, (Brinthaupt & Lipka, 2002; Brown, 2004; Erikson, 
1968; Sebastian, Burnett & Blakemore, 2008) therefore MRKH may pose particular 
challenges in this context. 
Perceived gender role inadequacy in the transition to adulthood has been shown to be 
related to depression and anxiety in the short term, and to predict poor adult adjustment in the 
longer term (Aubé & Koestner, 1992; O’Heron & Orlofsky, 1990). Further, growing 
independence from one’s parents and increasing focus on social and sexual relationships 
during this life stage leads to an emphasis on social acceptance, with much time and effort 
being dedicated to building peer relationships (Engels & van den Eijnden, 2007; Parker, 
Rubin, Price & DeRosier, 1995). The challenge that MRKH poses to one’s sense of self, 
gender identity, and social and sexual relationships may therefore be particularly problematic 
during the transition to adulthood. Indeed, Heller-Boersma (2006) found that distress is 
greatest immediately after diagnosis of MRKH and Bean et al. (2009) suggested that this time 
period is one which may benefit most from psychological intervention. These young women 
are being asked not only to cope with the transition to adulthood but also to cope with and 
adjust to a diagnosis of MRKH. It is therefore pertinent to understand the experience of 
MRKH at this particular stage in order to inform the development of sensitive and timely 
care, and to help prevent longer term adjustment difficulties. 
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The current study set out to investigate young women’s experiences shortly after 
being diagnosed with MRKH in order to understand their experiences at this critical stage of 
development. A qualitative approach, using Interpretative Phenomenological Analysis (IPA, 
Smith, 1996) to analyse data, was employed in order to explore the young women’s lived 
experiences. IPA deals with significant and emotional life changing experiences and has been 
found to be an appropriate method for exploring health and illness, sexuality, psychological 
distress, life transitions and identity (Smith & Osborne, 2003; Smith & Osborne 2008).  
 
Aims 
The study aimed to explore young women’s experiences of MRKH in order to address 
the following broad research questions; 
- What are young women’s experiences of having a diagnosis of MRKH? 
- What are the social and emotional challenges faced by young women with a diagnosis of 
MRKH? 
- How do individuals manage a diagnosis of MRKH in relation to their developing identities? 
 
Method 
Participants 
Five females with MRKH participated, aged 18 to 22 years old. This is within the 
recommended sample size for Doctorate level research studies employing IPA and enabled 
data saturation whilst allowing for a detailed interpretative account of each participant’s 
experiences (Smith, Flowers & Larkin, 2009; Smith & Osborne, 2008). Participant 
information is shown in Table 1, using pseudo names to maintain anonymity. Time since 
diagnosis was determined by the participants’ own reports of when they were diagnosed 
rather than being based on a formal diagnosis per say. This was due to variable delays 
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between professionals indicating that the young women had MRKH and having this 
confirmed by a MRI scan. The participants’ perception of the time when they were diagnosed 
was thought to best represent when it first became salient for them.  
The Scottish Index of Multiple Deprivation (SIMD) was used to determine the socio-
economic status of participants. The SIMD provides a ranked list of postcodes in Scotland 
from the most (rank 1) to least (rank 6505) deprived area based on indictors from seven 
domains: income, employment, health, education, skills and training, housing, and geographic 
access and crime. None of the participants’ post codes were within the 25% most deprived 
areas in Scotland (rank 1627 and under) and three fell within the 25% least deprived areas 
(ranked 4879 and above) indicating that study participants were of a middle to high 
socioeconomic status.  
 
Table 1: Participant information 
Participant pseudo name   Age Time since diagnosis SIMD rank 
Susan    22             5 years 5955 
Catherine    22             5 years 5329 
Katy    22             4 ½ years 5493 
Louise    18             1 ½ years 1687 
Fiona    18             2 years 3946 
 
 
Inclusion and Exclusion Criteria 
Inclusion and exclusion criteria were developed with the aim of maintaining a 
homogeneous sample. Women were invited to participate if they were aged 16 or over and 
had a formal diagnosis of MRKH at least six months prior to being interviewed. Participants 
54 
 
who were over 25 years old, who had been diagnosed more than five years previously, or who 
did not speak English as their first language were excluded.  
 
Recruitment 
Participants were recruited through a multi-centre genetics study taking place 
throughout Scotland; Spectrum of Clinical and Genetic Abnormalities in Women with 
Congenital Abnormalities of the Female Reproductive Tract. Potential participants for the 
genetics study were identified through the Scottish Disorders of Sex Development (SDSD) 
database; a central register set up to contain a core dataset of patients seen by the SDSD 
multidisciplinary team.  
Women were contacted by their named clinician or local gynaecologist and given an 
information sheet (Appendix 2.2) about the overall study before being invited to a clinic to 
discuss any questions or concerns, and to provide written consent (Appendix 2.3). As part of 
the consent process, potential participants were asked to agree to be interviewed for this 
study. 
Women who met the current study’s inclusion and exclusion criteria were then 
contacted to arrange a suitable time and place to meet to carry out the interview. When there 
had been a delay of more than two weeks between consenting for the study and being 
contacted to arrange the interview, a letter and stamped addressed envelope were sent 
requesting that the women return a reply slip indicating they still wished to participate 
(Appendix 2.4). Women who had consented to the study within the past two weeks were 
telephoned to arrange a suitable time and location to meet. 
Considerable efforts were made to achieve the final sample size. Problems were 
identified with the SDSD dataset due to the fact that the number of people recorded on the 
dataset with a diagnosis of MRKH was below the expected level given the known prevalence 
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rate of the condition. It also became apparent that some women who had been seen by 
services were not registered on the database. Further, the contact details available for those on 
the dataset were at times found to be incorrect. Gynaecology clinic lists were therefore hand 
searched in order to identify potential participants and regular contact was made with 
professionals working as part of the SDSD multidisciplinary team throughout the recruitment 
period to ensure all women who met the study criteria were identified. 
Six women initially provided consent, and five agreed to participate at the time of the 
interviews.  One woman did not reply to a letter or a telephone message asking her to contact 
the researcher to arrange a suitable time to meet, therefore no further contact was made. 
Another three women were identified who met the study criteria, one from the SDSD 
database and two from clinic lists. Unfortunately they did not respond to invitations to attend 
a clinic to discuss the wider study.  
 
Semi-Structured Interview 
Non-directive, semi-structured interviews were used to explore the young women’s 
experiences of MRKH. Care was taken at the start of each interview to make it clear to the 
young women that the researcher was interested in their views as experts on their own lives. 
A topic guide was used to help structure the dialogue, while the interviewer remained alert to 
different topics raised by the participants themselves and encouraged the exploration of these.  
Considerable thought went into the development of the topic guide, taking guidance 
from a Clinical Psychologist working in the field, and drawing on past research concerning 
adolescence, infertility and MRKH. The resulting guide covered the experience of, and 
feelings in relation to, initial diagnosis, the effect of MRKH on their life in general, 
experience of talking to peers and family members, sense of identity, experience of intimacy, 
and concerns for the future (See Appendix 2.5 for topic guide). Additional probe questions 
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were used to explore participant’s views (e.g. Can you tell me more about that? How did that 
make you feel?).  
Due to the sensitive nature of the topics covered, care was taken to ensure that 
participants felt at ease and that a rapport was developed before discussing the most personal 
areas. Care was taken to try to avoid asking leading questions.  
The interviewer summarised key points made by the participants to check her 
understanding. These summaries also provided the opportunity for the participants to correct 
misconceptions and opened up topics for further discussion. At the end of the interviews time 
was taken to check how the participant was feeling and to ask if there was anything else they 
would like to discuss. Interviews lasted between 32 and 46 minutes (mean 37 minutes). 
 
Procedure 
Interviews were digitally recorded and were carried out in a NHS clinic which was 
convenient for each participant to travel to. Travel expenses to reimburse the cost of public 
transport to attend the interview were offered to all participants. When they attended the 
interview the young women signed a further consent form agreeing to the interview being 
voice recorded and to quotations being used in published reports (Appendix 2.6). They were 
also given the opportunity to ask any questions prior to the interview commencing. 
 
Researcher reflexivity 
Although IPA aims to generate understanding through participants’ perspectives of 
phenomena, there is an acknowledgement that the researcher brings their own pre-existing 
beliefs to the process and plays an active role in interpreting the data (Reid, Flowers & 
Larkin, 2005). Therefore, care was taken to acknowledge the researcher’s own experiences 
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and beliefs, and to consider how these may influence the interpretation of participants’ 
experiences. 
The researcher had observed a Clinical Psychologist working therapeutically with 
women with MRKH.  She had also worked clinically with other populations who experience 
complications with fertility and this had provided insight into the typical challenges faced, 
and potential reactions to these. As the researcher was at a life stage where she was beginning 
to think about when she would like to start her own family, she also remained aware of her 
personal feelings about what being able to carry a child meant to her. 
 
Data Analysis 
Interviews were transcribed verbatim by the researcher. Each participant was allocated 
a pseudo name and other potentially identifying information was anonymised. Transcripts 
were analysed using IPA, as described by Smith and Osborne (2008). This involved repeated 
and careful reading of the transcripts whilst listening to the digital recordings. Points of 
significance were noted line by line. The researcher then re-read the transcripts and noted 
recurring themes. Emerging themes for each interview were compared and integrated, noting 
similarities and discrepancies between them.  Themes were clustered together and their 
relationship to each other considered in order to generate super ordinate themes. Capturing 
the participants’ personal experiences of MRKH as experts was the aim of this process. The 
transition to adulthood provided the main context for the interpretation of the participants’ 
accounts. See Appendix 2.7 for a sample extract of an analysed interview.  
In order to ensure a rigorous and transparent process, a reflective journal was kept to 
record the key decisions made and the reasoning behind these. Identified themes were 
discussed in research meetings as a means of audit, and two transcripts were analysed 
independently by a research supervisor to further verify the reliability of the analyses (Elliott, 
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Fischer & Rennie, 1999; Reid et al., 2005). Ultimately, themes were linked back to quotations 
from the interviews to ensure they continued to represent the essence of the women’s 
experiences. 
 
Ethical approval 
Ethical approval was awarded by the relevant NHS ethics committee, as part of the 
study Spectrum of Clinical and Genetic Abnormalities in Women with Congenital 
Abnormalities of the Female Reproductive Tract (Appendix 2.8). 
 
Results 
Four themes concerning the experience of MRKH in the transition to adulthood 
emerged from the interviews: (i) hindering independence, (ii) a sensitivity to difference, (iii) 
managing intimacy and (iv) managing threat to identity; dealing with a disrupted 
developmental process. See Appendix 2.9 for a table of themes and their main dimensions. 
Quotations from the interviews have been selected to help illustrate each theme. For 
clarity, participant quotations are presented in italics, with pauses in their speech indicated by 
a series of three dots. Author responses are written in parentheses. 
 
Hindering independence 
The women described their diagnosis as being intensely sensitive and personal to 
them. The enormity of discussing MRKH with others came across throughout the interviews, 
with the young women expressing feelings of it being a social taboo and a desire to keep their 
diagnosis private. 
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‘I just, kind of a private thing that I just didn’t think people would talk about, it’s 
not really a thing that a lot of people talk about. (Okay) So I just didn’t really 
want to talk about it myself.‘ Fiona 
 
Despite the deeply personal nature of MRKH, and the young women being at a stage 
when one typically becomes less dependent on one’s parents, participants described their 
mothers being heavily involved around the time of their diagnosis.  Some felt that their 
mothers took the lead in consultations with professionals; deciding on when to initially attend 
the GP and asking questions throughout the process. This resulted in participants feeling they 
had not been at the centre of their care. Susan chose to attend appointments by herself. 
However, as shown below, she was irritated by her mother’s questioning after appointments. 
Here she portrays a desire to manage the process on her own, with her mother’s questions 
being perceived as an intrusion on her privacy. 
‘but my mum, you know, every time I go for an appointment she’s always like 
‘what’s happened, what’s happened?’, and I’m like ‘it’s got nothing to do with 
you mum, just leave it.’’ Susan 
 
In addition, Katy felt that the professionals she saw in relation to her diagnosis did not 
recognise her growing autonomy, challenging her perception of herself as an independent 
adult. In the example below she shows her frustration about this.  
 ‘I just didn’t like him, (be)cause I asked him questions and he ignored me and ... 
he just talked to my mum, so I was like ‘I am an adult’’ Katy  
 
Many participants described their mothers’ strong emotional reactions to their 
diagnosis, with one mother being said to have had a panic attack. Some believed that these 
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intense reactions were due to their mothers being so involved in the process of diagnosis that 
they felt it was happening to them first hand. It may also be that, as mothers themselves, they 
reflected back on their experiences and of what their daughters may miss out on through not 
being able to carry a child. Catherine also felt that receiving a diagnosis of MRKH caused her 
mother to be protective of her, talking in terms of a mother-child relationship, rather than a 
more adult  relationship. 
‘I think (Catherine laughs) it affected my mum probably more. She was quite, like, 
distressed but that’s kind of, you know, finding out there is something wrong with 
your child I suppose.’  Catherine  
 
Another way in which the participants’ growing independence appeared to be 
hindered was in relation to disclosure of their diagnosis to others, with over half of the 
participants stating that their mothers had told other family members that they had MRKH. In 
two instances, the participant had not told anyone apart from their mother about their 
diagnosis, hence the only way others knew was through being told by their mother. Louise 
felt that she had no power over who knew, with the words ‘everybody’ and ‘absolutely’ 
emphasising a real sense of feeling this had been spiralling out of her control.   
 ‘My mum, I didn’t really want everybody in my family knowing but my mum told 
absolutely everybody (Louise laughs).’ Louise 
 
MRKH seemed to complicate the ongoing negotiation of the mother-child relationship 
to a point where it was difficult for the young women to remain in control of their lives. Their 
wishes to keep their diagnosis private due to the personal nature of MRKH were undermined 
by their mothers’ own beliefs about who should be told, or perhaps their mothers’ own need 
to discuss the diagnosis with others due to their emotional reactions. Below, Fiona describes 
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such opposing beliefs. Here, her own wishes were overridden by her mother’s, resulting in 
not only her privacy, but also her autonomy as an adult, being compromised.  
 ‘I kind of ... I didn’t really want them to know (be)cause it’s, it was like, my, 
private kind of thing, but if, my mum said ‘well it would be better if they knew’, 
(be)cause it would, like, I’d be awkward in the future trying to tell them, but at the 
moment I just, didn’t really want anybody to know, just kind of wanted to deal 
with it first and then tell them.’ Fiona 
 
A sensitivity to difference 
The interviews revealed feelings of being different to others and the situations where 
such feelings come to the fore. Some participants felt that they could not take part in certain 
conversations with their peers due to their different experiences, such as discussing 
menstruation. All women also mentioned being around children or those who were pregnant 
as being difficult for them, provoking a sense of loss of normality and anticipated future loss. 
Below, Fiona reflects on being around others with their children, and how adopting her 
children would compare to being a birth mother. 
‘it just like makes me feel ‘right, I can’t have that kind of bond’. But, I know it’s 
going to be my child in the end, but it’s not actually really mine. (Mm hmm) So I 
think that’s just, kind of ... daunting to think that (yeah) but, it’s just, kind of, hard 
to, kind of, think ‘aw ... they’re not actually really going to be my ... children.’ 
Fiona 
 
The young women’s feelings of being different from others and concerns about the 
future impact of such differences caused them to feel down and hurt. Louise provides an 
example of this, describing that she experienced a range of emotions which fluctuated daily.  
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‘But it’s, it started playing about wi(th) my mind so I was like down one day, and 
I’d be happy the next, and then just really depressed and, I don’t know, it just 
really took a lot from me so it did. It, like, it was bad, it was really bad.’ Louise 
 
Such feelings of being different and the subsequent impact on the young women’s 
emotions were in contrast to reports that, because they were not at the life stage where they 
were thinking about having children, they were not currently particularly affected by MRKH. 
Rather, they described their present priorities as being those more typically associated with 
the transition to adulthood, such as developing their careers. 
‘but at the moment it doesn’t affect us really at all, because ... it’s just, it’s, it’s 
not (Catherine laughs) having a uterus doesn’t really affect your day to day 
life? (Yeah) And you know, we’re kind of, you know, early twenties, we’re not 
really up to much which requires a uterus at the moment.’ Catherine 
 
Most participants described active attempts to try not to think about their diagnosis 
which appeared to be a means of allowing them to focus on more current priorities and those 
which were salient for their peers. Fiona’s description below shows her effort to do so, with 
her attempting to think about anything but her diagnosis.   
‘I’ve always kind of just pushed it to the back of my mind, so (mm hmm) it’s not 
really ... the thing I’m always thinking about, it’s the last thing I’m thinking about, 
so I’m, like, concentrating on other things. (mm hmm) So its, I don’t think it’s 
really affecting me right now, (be)cause I’m always just pushing it to the back of 
my mind.’ Fiona 
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It seems that, despite wishing to maintain a focus on current priorities and avoid 
thinking about their diagnosis, certain social contexts triggered feelings of difference for these 
young women, leading to them thinking ahead to future difficulties. Being sensitive to 
difference, they reported using avoidance to help minimise their exposure to such situations. 
In the example below, Katy shows that the hurt and feelings she experienced in response to 
feelings of difference was significant enough for her to change her planned career path. 
‘I mean, I always like, kind eh, just felt quite different and as an outsider and like 
... why am I different, why am I the one that can’t? And just ... kind eh, a wee bit 
gutted, but (Katy inhales) so I just took myself out of the situation rather than 
sorting the situation if that makes sense.’ Katy  
  
For Catherine, feeling different from others became a viewpoint from which she 
interpreted her life. Her reflective comment below show she has a tendency to view herself as 
categorically different, and that such differences are seen as the cause of the difficulties she 
experiences. This highlights how pervasive feelings of difference can be at a life stage in 
which peer acceptance is strongly sought.  
 ‘Emm ... I don’t know, it’s kind of an ir’, irrational response to a situation where 
you are singled out to assume that if you weren’t different then, like everything 
else in your life would be different in some way, or better in some way, but ... I 
mean you know, there’s, there’s been moments where you’ve, I’ve felt like that 
because you know, you’re down and you’re feeling ‘oh why has the world chosen 
me, why?’(Catherine laughs)’ Catherine 
 
In addition to participants feeling they did not fit in with others who could carry 
children, they also felt that those without MRKH were unable to understand their situation. 
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Although positive relationships with friends and family were described, the participants felt 
that only those who had MRKH could truly relate to their experiences, as Susan describes 
below. 
‘I mean my friends were very supportive but, so that was helpful, but I think 
because none of my friends obviously have MRKH, eugh, MRKH, it’s a bit 
different, you know, you could talk about it but only to a certain extent, you don’t 
get how they feel about having it as well kind of thing’ Susan 
 
Some of the women indicated that they would like to meet or talk to others with 
MRKH who they may be able to relate to more. Participants felt, however, that previous 
experiences of talking to women with MRKH on an internet forum had been of limited value 
as this had tended to be with older women, as shown by Susan below. They expressed a wish 
to meet or talk to others with MRKH who were of a similar age to them.  
‘I think ... emm, the websites weren’t actually that handy, because at the time I 
was 17 or 18 and all the people that had been diagnosed were 30s, 40s, they’d 
adopted, they’d, you know, had surrogate children et cetera, and it wasn’t, I 
didn’t feel particularly close to them because of the age gap.’ Susan  
 
Managing intimacy 
Participants expressed an overall sense that MRKH caused difficulties in partner 
relationships. Those who were in, or who had experience of, such relationships reported that 
it was difficult to negotiate when to tell their partners about their diagnosis. They seemed torn 
between waiting until further into the relationship to tell partners they had MRKH and telling 
them from the outset.   
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‘it’s kind of, (be)cause it’s obviously quite personal you know, and if you are only 
with them for, you know, a month or so because it doesn’t work out but, you don’t 
want to tell them too quickly, you don’t want to leave it too long either so I think 
that’s a thing I’ve always had trouble with.’ Susan 
As Susan describes above, on one hand participants wanted potential partners to know about 
their diagnosis of MRKH prior to them becoming invested in the relationship, however they 
also felt that they would rather not share such personal information if it was not to become a 
long term relationship. Those without experience of such relationships also discussed 
concerns for the future.  
 
Worries about potentially negative reactions from partners appeared to drive concerns 
about disclosure. Participants feared that prospective or current partners would want to end 
their relationships if they knew they had MRKH. In some instances, this was stated despite 
having found partners to be understanding and supportive. Some participants felt that men 
may not want to be in a relationship with them because they could not have children. Others, 
such as Louise, felt that relationships would not last beyond disclosure due to the more 
current potential difficulties with sexual relationships: 
‘When I say, ‘oh’, to a guy, ‘oh look I’ve got this problem’, I’ve, I feel as if they 
are just going to be like that ‘ooft no thanks, don’t want to go through it with 
you’, do you know what I mean?’ Louise 
  
Motivation to tell partners sooner partly related to wishing to avoid awkward 
situations. Susan, for example, explained that when partners did not know she had MRKH she 
felt unsure how to respond when they asked about her use of contraception, and embarrassed 
about needing to use lubrication to participate in sexual intercourse. 
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Difficulties with negotiating intimacy resulted in two of the participants avoiding 
becoming involved in romantic and sexual relationships for long enough for this to become 
an issue. The quotation below shows Katy’s active attempts to escape this difficult 
conversation by not allowing relationships to progress to a more serious level. 
 ‘That’s something I’ve always done by pushing people away, so it’s just part of, 
my nature, and I wanted to avoid telling them. So I just pushed them away.’ Katy 
 
Two participants had been friends with their current partners prior to entering a more 
intimate relationship, hence the partner either already knew they had MRKH or the women 
felt able to trust them from the outset of their relationship. As shown below, Catherine talked 
about being conscious that this made it easier for her to talk to her partner about having 
MRKH. 
‘Well I mean, I wasn’t nervous (be)cause I knew him (mm hmm) so that was 
different. If it had been like a new relationship which I hadn’t known him as a 
friend or anything before it would have been different’ Catherine 
 
Likewise, Katy described how her current situation has allowed her to avoid full 
discussions about MRKH. Again, a sense of relief is apparent in relation to this. 
‘We’ve discussed minimal things but he doesn’t know, we’re not into any 
discussions about physical things until a wee bit later on in the relationship, 
because of issues at his end and mine, so ... there’s ... it, I’ve worked out quite 
well here that I don’t need to tell him for a wee bit yet (laughs)’ Katy 
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Catherine described feeling more confident when entering  intimate relationships than 
other participants. For her, having had previous sexual experiences where partners had not 
been able to tell she had MRKH allowed her to feel more comfortable about future intimacy. 
As she states below, knowing that others would not necessarily be aware of physical 
differences allowed her to feel more in control of who she told and when.  
‘(be)cause of when I found out, (be)cause I was like, you know, I’d had boyfriends 
and (inhales) and you know, I had already kind of like, you know, had, not, not 
sex with guys but um, I’d, you know, I’d done stuff with guys before I found out. 
So I hadn’t seen, I hadn’t, I think maybe if I’d found out earlier I would have like 
kind of avoided going into those sort of situations more? Because, I thought, I 
would think that I was way different from other guys, (be)cause I’d already kind 
of seen other guys and stuff before I found out I thought well obviously they 
didn’t, you know, they didn’t notice (Catherine laughs). So I guess I was more 
confident because of that.’ Catherine 
 
Managing threat to identity; dealing with a disrupted developmental process  
Participants spoke about MRKH having affected their developing sense of self in 
terms of their gender identity and self-esteem. They described a compromised female 
identity, feeling they were not complete as women because they were unable to participate in 
tasks typically associated with being a woman. For Louise, not having periods caused her to 
feel only part female as she had not completed the steps she saw as being involved in 
becoming a woman. Indeed, people’s gender identity usually becomes more consolidated 
following such experiences. 
 ‘basically what I mean was, in a way, like a girl goes through the stages of 
puberty, period, growth in the, the chest, and all that, and when I didn’t have my 
68 
 
period I was kind of like, when I got told that I wouldn’t never have a period, I 
was li(ke), I felt as if, that’s the stages a women goes through, like every month, 
having a period and getting the sore stomach and the cramp and, I just felt as if 
I’m never going to have that, so I part of thought that ... part woman, part of my 
woman side had gone.‘ Louise 
 
Child bearing was talked about as a fundamental role of a woman, hence the inability 
to carry a child was seen to be the most distressing aspect of their condition and posed a 
particular challenge to the young women’s core female identity. As indicated by Susan below, 
they felt that, by being unable to fulfil this central role, they were by definition incomplete as 
females.  
‘I think I feel a lot more ... kind of, boyish, if that makes sense, (right) like I’m not 
completely feminine since, (mm hmm) I suppose ... when you go down to the 
basics the whole point of being a female is that you provide, you know, have 
children and put the population up and stuff. So it does make me feel slightly less 
feminine’ Susan 
 
Susan also explained how she responded to these challenges to her female identity:  
 ‘I think ... I kind of try harder to be girly sometimes, so I’ll wear a lot of makeup 
(okay) and skirts and stuff, whereas before I didn’t bother. Then when I got the 
diagnosis I was like well I’ll just make sure everyone knows I’m a girl (Susan 
laughs).’ Susan 
 
This was in contrast to descriptions of herself as being a tomboy growing up, indicating 
that she had previously not been as concerned about appearing typically female. Hence, her 
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diagnosis of MRKH seemed to challenge her sense of self as female, leading to her being 
more sensitive about her identity as a woman and more concerned about how others saw her. 
She therefore made more active attempts to present herself as being typically female to 
others.  
 
The majority of participants also described feeling less confident than they had been 
prior to their diagnosis, both in general and in relation to developing intimate relationships. 
Participants appeared to feel less worthy of such relationships and believed that partners 
would be at a disadvantage to be with them rather than another woman. Louise’s lowered 
self-esteem and concerns about withholding typical experiences from her partner resulted in 
her ending their relationship. 
‘But I think it was because it did knock confidence off me I was just like ‘no, I 
want you eh have someone better, I want you be able to have a sex life, I don’t 
want you to be able t(o), I don’t want to be, like, not go through the stages that 
every man goes through, I don’t want eh take that away from you.’’ Louise 
 
In light of their lowered self-esteem, it was implied in the interviews that participants 
felt self-conscious about their diagnosis. They talked of thinking carefully about who to 
discuss having MRKH with and were concerned about people’s reactions to this. As 
Catherine demonstrates, other people’s perceptions of them were particularly salient and fear 
of potential negative responses prohibited them from talking about their diagnosis due to the 
effect this may have on them personally. This is in keeping with young adults being more 
conscious of, and more effected by, other people’s perceptions and suggested that the women 
saw MRKH as a potentially stigmatising condition. 
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‘see I think that’s why I don’t tell people if I don’t need to because I don’t find it’s 
an issue for me but people make things issues and then it can become an issue for 
you, it is kind of like a feedback thing.’ Catherine 
 
With concerns about what their peers think of them and lowered self-esteem, 
participants were worried that others would ‘find out’ about them having MRKH. Some felt 
that others would be able to detect that they had MRKH without being told. In the following 
quotation Katy shows that she was concerned about how she looks to others, believing that 
they would notice differences in her interactions in terms of lack of eye contact. This was in 
contrast to her actual presentation however, in which no obvious differences in the amount of 
eye contact were noted. Her concerns seemed to reflect her underlying emotions and inner 
worries about how she appeared to others, rather than her actual outer appearance.   
‘I, c’, can’t even look at people ... and discuss it, you know, emm, like, you’ve 
probably noticed that my eyes are going everywhere. I can’t, I can’t even look at 
you’ Katy 
 
Two participants talked of having integrated MRKH into their overall sense of self and 
reported that it no longer affected them. In both instances, however, contradictions were 
noted throughout the interviews with these participants also describing active attempts to 
suppress thoughts and feelings about MRKH.  This alludes to a sense of managing how they 
present themselves to others in order to preserve their previous sense of self and other’s 
opinions of them. 
 
The women were keen to discuss their experiences in the interviews, however the social 
nature of the interaction caused them to manage how they presented themselves in order to 
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preserve their self-esteem. Some participants appeared to make light of the impact of MRKH 
throughout the interviews which seemed to be a means of managing how they were perceived 
and to help protect against their emotional reactions. Susan in particular often used humour at 
emotionally salient points of the interview. In the example below, she talks about her 
experience of talking to older women who have MRKH. Humour is used to buffer her 
concern about not having a partner or children in the future, controlling the emotions she 
portrayed to the researcher. 
‘they’d obviously come out the other end and had children and husbands and stuff 
like that so (right, okay) that was helpful to know that I wasn’t (yeah) going to die 
lonely with a heard of cats (Susan laughs)’ Susan 
 
Susan also described using humour in other situations as a way of managing people’s 
reactions to her diagnosis. It seemed that she wished to indicate to others how they were to 
respond in order to protect herself from being faced with their emotional reactions, and from 
potential negative reactions having an effect on her sense of self. 
‘Emm ... I think ... some people, because I joked about it I think some of them were 
a bit shocked, and that irritated me a little bit because it’s not really anything to 
do with them ... it’s me, you know, it’s not them that’s going through it, so, if I 
want to make jokes about it then they should just accept that and shut up (Susan 
laughs).’ Susan 
 
Discussion 
This paper has presented the lived experiences of five young women who had 
received a diagnosis of MRKH within the past five years. Interviews were interpreted in the 
context of the transition to adulthood, resulting in four emerging themes; hindering 
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independence, a sensitivity to difference, managing intimacy and managing threat to identity; 
dealing with a disrupted developmental process. 
As found by previous research, the women reported that their diagnosis caused them 
to feel down, different from others and to fear partner rejection (Bean et al., 2009). Being 
unable to carry a child was considered to be the most distressing aspect of having MRKH, 
again supporting previous literature (Bean et al., 2009; Kimberley et al., 2011). Bean et al.’s 
(2009) and Holt and Slade’s (2003) findings that MRKH poses a challenge to women’s core 
female identity and self-esteem, seeing themselves as being incomplete as women because 
they are unable to fulfil what they consider to be their fundamental role of childbearing, were 
also corroborated in the current study. This may be particularly problematic in the transition 
to adulthood where identity formation and reaching reproductive potential are key 
developmental tasks, and where gender role inadequacy has been found to relate to poor 
adjustment in later life (Aubé & Koestner, 1992; Brindthaupt & Lipka, 2002; Erikson, 1967; 
Marcia, 1966; O’Heron & Orlofsky, 1990).  
In addition to supporting key concepts from previous literature, the themes identified 
interlink to offer a unique insight into the subtleties of the complex experience of MRKH in 
the transition to adulthood. At a stage where peer acceptance is highly sought and one is 
increasingly affected by other’s perceptions (Engels & van den Eijnden, 2007; Parker et al, 
1995; Seiffge-Krenke, 1998), the young women’s sensitivity to the social impact of their 
diagnosis was apparent in their concerns about others knowing or ‘finding out’ they had 
MRKH, and the effect that others’ reactions may have on their sense of self. Despite the 
pervasive impact of MRKH on their personal identities and emotional well-being, the women 
went to huge efforts to keep their diagnosis private, to present themselves as ‘typically’ 
female, and to avoid situations which may single them out. This is in keeping with Goffman’s 
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(1959) notion of a hidden stigma where one tries to manage information about one’s self in 
order to avoid being devalued by society.  
The women’s attempts to manage the disclosure of their condition and to maintain a 
sense of privacy about this personal and sensitive area were, however, complicated by their 
mothers taking the lead in telling family members about their diagnosis and, in some 
instances, professionals directing information to their parents. Not only did this undermine 
their desire for privacy, but it also hindered the re-negotiation of the parent-child relationship 
towards independence that typically occurs at this life stage (Bee, 1975, Engels & van den 
Eijnden, 2007; Larson & Richards, 1991). This may be problematic in the longer term as 
independent decision making in mid to late adolescence has been found to relate to better 
adjustment in adulthood (Smetana, Campione-Barr & Daddis, 2004). 
When the young women were in situations where they had to discuss their MRKH 
with others, they again described using strategies to manage the discourse. This was evident 
in the interviews themselves, with some participants using humour as a means of managing 
the conversation. Managing the disclosure of MRKH in intimate relationships was also 
described as a particular challenge for these young women at a life stage where romantic and 
sexual relationships typically begin to develop, and hence where individuals need to negotiate 
the particulars of this new type of interpersonal situation (Collins, Welsh & Furman, 2009). 
The intimate nature of these relationships meant they wanted to discuss MRKH with partners 
from the outset to avoid awkward situations, but at the same time they wanted to wait until 
they had developed a sense of trust in their partners to avoid potential rejection or becoming 
subject of gossip. For some, this negotiation was so difficult that they avoided developing 
romantic relationships. This is of concern as having such relationships is commonly 
associated with feelings of positive self-worth (Connolly & Konarski 1994, Harter 1999). 
Their coping strategies may therefore have led to greater distress. Avoidance of wider social 
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situations may have similarly been ineffective in the longer term, by reducing the opportunity 
to build relationships with their peer group, and hence may have heightened their feelings of 
difference. 
The interviews therefore showed that, although the young women felt that being 
unable to carry a child would have a significant effect on them in the future, during the 
transition to adulthood it was the challenges that MRKH posed in social settings which cause 
the most distress. Although Heller-Boersma et al.’s (2007, 2009b) cognitive behavioural 
model of MRKH addresses some of the self-appraisals evident in these young women’s 
reports, and to an extent their coping strategies in terms of appearing as a ‘proper’ woman to 
others, the social context which largely influenced these is not considered. The model’s focus 
on failure to adequately process the diagnosis did not come across as a core feature of these 
young women’s experiences, suggesting it does not adequately described the lived experience 
of MRKH in the transition to adulthood. Further, the model’s assumption that idiosyncratic 
negative appraisals are partly due to cognitive immaturity at the time of diagnosis is not 
supported by a review of inferility literature which showed women of various ages to report 
similar self beliefs (Espie, this volume). 
 
Strengths and weaknesses 
Although within the sample size recommended for doctorate level research employing 
IPA, the study sample was lower than initially intended. Despite there being a national 
database proposed to hold information on all those diagnosed with a disorder of sex 
development, the number of individuals with MRKH was lower than would be expected 
given the population of Scotland and reported prevalence rates of the condition. This suggests 
that a large proportion of women with MRKH are not in contact with services. This study 
therefore represents a particular sub-group of young women who remain engaged with 
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services. The views and experiences of those who have chosen not to have contact with 
services may be different, hence they are an important group to include in future studies.  
Secondly, only one interview was conducted with each participant. Although all were 
offered the opportunity to raise additional areas they wished to discuss at the end of the 
interview, participants had no opportunity to broach any further dimensions that came 
forward after reflecting on the interview. This paper therefore explores their experiences as 
described at a single moment in time. Finally, although the researcher reflected on her impact 
on the process throughout, her interpretations may have been influenced by how important 
having a child in the future is to her, and by how she imagines she would feel if this was not 
possible.  
In terms of study strengths, considering the participants’ experiences in their 
developmental context has allowed for a detailed understanding of MRKH in the transition to 
adulthood. This experience has not been captured by quantitative research or in studies 
looking at women from a broad age range and at different life stages. Those who took part 
were keen to discuss their experiences and the richness of data collected suggests that they 
felt comfortable to talk openly and honestly despite the personal nature of issues covered. It 
may be that the researcher herself being a young woman and having no clinical agenda 
facilitated this process. This being said, however, the impact of dealing with MRKH in social 
settings was evident during the interviews, with the participants containing their emotional 
reactions and managing how they presented themselves to the interviewer. 
Exploring topics as they were brought to the interview by participants also enabled 
them to discuss their experiences without being restricted by the researcher’s own agenda or 
beliefs. Reaching a point of data saturation further validated that the study has explored a full 
range of issues which help to explain young women’s experiences of MRKH. Every attempt 
was also made to ensure a transparent and rigorous process through having two transcripts 
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analysed by a second researcher as a means of audit, discussing emerging themes in research 
meetings, and keeping a reflective diary.  
Implications 
This study suggests that psychologically informed care for women with MRKH needs 
to consider adjustment within a developmental context. Support groups specifically for young 
women with MRKH may be beneficial in creating a safe environment for them to talk to 
others of a similar age to increase a sense of peer group acceptance and to help reduce 
feelings of inadequacy and difference. Group based psychological interventions have indeed 
been found to be effective for reducing psychological distress in women with MRKH (Heller-
Boersma et al., 2007; Weijenborg & terKuile, 2000), however the active components of these 
interventions have not been considered. It may be that social support alone contributes to the 
effectiveness of these groups. 
Professionals should also consider how best to manage their communication with 
young women and their families, rather than assume a straight forward parent-child 
interaction in which the parent takes the lead. Given the growing need for autonomy in the 
transition to adulthood, removing the young women from the centre of their care is potentially 
damaging to their development. Efforts should therefore be made to keep the young women 
informed and to allow them to have an active role in decision making.  Given the strong 
emotional reactions on the part of the women’s mothers, and their need to discuss their 
daughters’ diagnosis with others, a support network for parents may also be beneficial.  
Further, psychologically informed support in the short term after diagnosis which 
focuses on identity, social competence and adaptive coping strategies is advised. 
 
Future Directions 
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Further qualitative work exploring the specific experiences of MRKH at different life 
stages would be warranted to develop holistic longer term care needs. The development of 
psychologically informed interventions targeting the specific effects of MRKH during the 
transition to adulthood is required in order to provide timely care and avoid potential longer 
term negative consequences. 
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CHAPTER 3: ADVANCED PRACTICE 1: REFLECTIVE CRITICAL 
ACCOUNT 
 
 
 
Case complexity, a tick box exercise? The role of clinical psychologists in physical 
health settings 
 
(Abstract only) 
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Abstract 
 
Introduction: This reflection focuses on the thoughts and feelings I experienced during a 
meeting to discuss the role of clinical psychologists in physical health settings. The recent 
government HEAT access target for psychological therapies and The Matrix, A Guide to 
Delivering Evidence-Based Psychological Therapies in Scotland, are discussed in order to set 
the context of my reflection. I discuss the recommendations for clinical psychologists to work 
with the complex cases which require intensive intervention. Gibbs’ (1988) model was used 
to guide my reflection, however not wanting to be restricted by this model, I also followed 
my natural train of thought, as promoted in psychoanalysis.  
Reflection: I first describe the meeting that my reflection stemmed from, detailing the 
thoughts and feelings I experienced. I then draw on experiences of my clinical work in 
physical health settings to help me evaluate and make sense of these reactions.  From my 
initial concern that as a health aligned trainee I had little opportunity to work with ‘complex’ 
cases, I come to recognise the true value of my training experiences and the developments in 
my clinical practice.  I also recognise the importance of the wider role of a clinical 
psychologist in teaching and providing consultancy and supervision for other professionals, 
particularly when working in settings which largely adopt a medical model. 
Reflective review: This reflection has allowed me to recognise the need for clinical 
psychologists to be involved in commissioning services and the value of reflection for 
personal learning.  
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CHAPTER 4: ADVANCED PRACTICE 2: REFLECTIVE CRITICAL 
ACCOUNT 
 
Providing consultancy in medical settings: challenge or opportunity? 
 
(Abstract only) 
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Abstract 
 
Introduction: The current reflection stems from my thoughts and feelings in response to a 
conversation with a nursing colleague regarding her management of, and reaction to, a 
difficult situation. The extended roles of a clinical psychologist in terms of providing 
supervision, consultancy and training, as promoted in The Matrix, A Guide to Developing 
Evidence-Based Psychological Therapies in Scotland and Applied Psychology and 
Psychologists in Scotland, are discussed in order to provide the context for the reflection. As 
previously found helpful, Gibb’s (1988) reflective model was used to guide the reflection, 
however I also followed my natural flow of thought in order to freely explore this experience.  
Reflection: I describe the conversation which triggered my reflections and consider my 
thoughts and feelings in relation to three elements of this discussion, namely the practical, 
emotional and personal levels. I then consider why I found this situation challenging, 
highlighting the need to develop my skills in providing consultancy regarding staff reactions 
to client presentations, and recognising the importance of formalising supervision 
arrangements with future supervisees. Finally, I consider the subsequent development of my 
competence in offering advice and training on emotional responses to professional work. My 
reflections are concluded by a recognition of these extended roles being an opportunity to be 
grasped in order to promote psychologically informed care in medical settings. 
Reflective review: The current reflection has also encouraged me to think more fully of my 
own emotional reactions to my clinical work and to be mindful of these as potential barriers 
to effective intervention. 
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91 
 
 Manuscripts should be compiled in the following order: title page; abstract; keywords; 
main text; acknowledgments; appendixes (as appropriate); references; table(s) with 
caption(s) (on individual pages); figure caption(s) (as a list). 
 Abstracts of no more than 200 words are required for all papers submitted. 
 Each paper should have up to six keywords . 
 Search engine optimization (SEO) is a means of making your article more visible to 
anyone who might be looking for it. Please consult our guidance here . 
 Section headings should be concise. 
 All the authors of a paper should include their full names, affiliations, postal 
addresses, telephone numbers and email addresses on the cover page of the 
manuscript. One author should be identified as the corresponding author. The 
affiliations of all named co-authors should be the affiliation where the research was 
conducted. If any of the named co-authors moves affiliation during the peer review 
process, the new affiliation can be given as a footnote. Please note that no changes to 
affiliation can be made after the article is accepted. 
 Please supply a short biographical note for each author of no more than 100 words. 
 For all manuscripts non-discriminatory language is mandatory. Sexist or racist terms 
should not be used. 
 Authors must adhere to SI units . Units are not italicised. 
 When using a word which is or is asserted to be a proprietary term or trade mark, 
authors must use the symbol ® or TM. 
2. Style guidelines 
• Description of the Journal’s article style and quick guide 
• Description of the Journal’s reference style and quick guide 
• Guide to using mathematical symbols and equations 
• Word templates are available for this journal. If you are not able to use the template 
via the links or if you have any other template queries, please contact 
authortemplate@tandf.co.uk 
Meta-analyses and systematic reviews 
In order to comply with international standards and for academic transparency, authors of 
meta-analyses and systematic reviews submitted to Health Psychology Review are required to 
include a statement in accordance with the Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses (PRISMA) statement ( http://www.prisma-statement.org/ ) as a 
supplemental file for review (the final document will be included as online supplemental 
material). In addition, authors of meta-analyses should include the information recommended 
by the APA's Meta-Analysis Reporting Methods (MARS) which can be found here ( 
http://www.apastyle.org/manual/related/JARS-MARS.pdf) 
Competing interests 
A competing interest exists when your interpretation or presentation of information may be 
influenced by your personal or financial relationship with other people or organizations. 
Authors should disclose all financial and non-financial competing interests. 
92 
 
Authors are required to complete a declaration of competing interests and submit it together 
with the manuscript. All competing interests that are declared will be listed at the end of 
published articles. Where an author gives no competing interests, the listing will read 'The 
author(s) declare that they have no competing interests'. Please consider the following 
questions: 
• In the past five years have you received reimbursements, fees, funding, or salary from 
an organization that may in any way gain or lose financially from the publication of 
this manuscript, either now or in the future? Is such an organization financing this 
manuscript? If so, please specify. 
• Do you hold any stocks or shares in an organization that may in any way gain or lose 
financially from the publication of this manuscript, either now or in the future? If so, 
please specify. 
• Do you hold or are you currently applying for any patents relating to the content of the 
manuscript? Have you received reimbursements, fees, funding, or salary from an 
organization that holds or has applied for patents relating to the content of the 
manuscript? If so, please specify. 
• Do you have any other financial competing interests? If so, please specify. 
If you are unsure as to whether you, or one of your co-authors, has a competing interest 
please discuss it with the editorial office. 
Authors' contributions 
All authors are expected to have made substantive intellectual contributions to, and to have 
been involved in drafting or revising the manuscript. Each author should have participated 
sufficiently in the work to take public responsibility for appropriate portions of the content. 
Acquisition of funding, collection of data, or general supervision of the research group, alone, 
does not justify authorship. With the submission of a manuscript, it is assumed that all authors 
have read and approved the final manuscript. 
Acknowledgements 
All contributors who do not meet the above criteria for authorship, should be listed in an 
acknowledgements section in accordance with the APA guidelines. The acknowledgements 
should be contained on the title page of the manuscript as making acknowledgements 
available to reviewers will compromise the masked peer-review process. Examples of those 
who might be acknowledged include those who provided general, technical, or writing 
assistance. Acknowledgement of funding/grants are also included in this section. 
4. Figures 
• It is in the author's interest to provide the highest quality figure format possible. 
Please be sure that all imported scanned material is scanned at the appropriate 
resolution: 1200 dpi for line art, 600 dpi for grayscale and 300 dpi for colour. 
• Figures must be saved separate to text. Please do not embed figures in the paper file. 
• Files should be saved as one of the following formats: TIFF (tagged image file 
format), PostScript or EPS (encapsulated PostScript), and should contain all the 
necessary font information and the source file of the application (e.g. CorelDraw/Mac, 
CorelDraw/PC). 
93 
 
• All figures must be numbered in the order in which they appear in the paper (e.g. 
Figure 1, Figure 2). In multi-part figures, each part should be labelled (e.g. Figure 
1(a), Figure 1(b)). 
• Figure captions must be saved separately, as part of the file containing the complete 
text of the paper, and numbered correspondingly. 
• The filename for a graphic should be descriptive of the graphic, e.g. Figure1, 
Figure2a. 
5. Colour 
The Journal has no free colour pages within its annual page allowance. Authors of accepted 
papers who propose publishing figures in colour in the print version should consult Taylor & 
Francis at proof stage to agree a financial contribution to colour reproduction costs. Figures 
that appear in black-and-white in the print edition of the Journal will appear in colour in the 
online edition, assuming colour originals are supplied. 
6. Reproduction of copyright material 
As an author, you are required to secure permission to reproduce any proprietary text, 
illustration, table, or other material, including data, audio, video, film stills, and screenshots, 
and any supplementary material you propose to submit. This applies to direct reproduction as 
well as “derivative reproduction” (where you have created a new figure or table which 
derives substantially from a copyrighted source). The reproduction of short extracts of text, 
excluding poetry and song lyrics, for the purposes of criticism may be possible without 
formal permission on the basis that the quotation is reproduced accurately and full attribution 
is given. 
For further information and FAQs, please see 
http://journalauthors.tandf.co.uk/preparation/permission.asp 
Copies of permission letters should be sent with the manuscript upon submission to the 
editors. 
• Copyright permission letter template 
7. Supplementary online material 
Authors are welcome to submit animations, movie files, sound files or any additional 
information for online publication. 
• Information about supplementary online material 
 
 
 
94 
 
Appendix 1.2: Quality Rating Criteria (based on Walsh & Downe, 2006) 
Stage Essential criteria 
Scope and purpose - Clear statement of focus for research  
- Rationale for research  
- Questions/aims/purpose 
- Study thoroughly contextualised by existing 
literature 
Design - Method/design apparent 
- Above consistent with research intent 
- Rationale given 
- Data collection strategy apparent  
- Data collection strategy appropriate 
Sampling strategy - Sample and sampling method explained  
- Above justified 
- Above appropriate 
Analysis - Analytic approach explained  
- Above appropriate 
- More than one researcher involved if 
appropriate 
- Participant involvement in analysis 
- Evidence of data saturation/discussion or 
rationale if did not 
Interpretation - Context described  
- Context taken account of in interpretation 
- Clear audit trail (sufficient so others can 
follow decision trail) 
- Data used to support interpretation 
Reflexivity - Researcher reflexivity demonstrated 
Ethical dimensions - Ethical approval granted 
- Documentation of how consent was managed 
- Documentation of how confidentiality and 
anonymity were managed 
Relevance and transferability - Relevance and transferability evidence 
- Links to theories and literature 
- Limitations/weaknesses outlines 
- Outlines further directions for research 
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Appendix 2.2: Information sheet 
Dr R McGowan 
Specialist Registrar Clinical Genetics 
Dept of Clinical Genetics, 
Ferguson-Smith Centre 
Yorkhill, Glasgow, G3 8SJ 
Tel: 0141 201 0808         Fax: 0141 201 0361                                    
e-mail: ruth.mcgowan@ggc.scot.nhs.uk 
 
 
 
PARTICIPANT INFORMATION SHEET 
 
Title of Project: Study Investigating Women with Variations in the 
Development of the Reproductive System 
 
Name of Principal Investigator: Dr Ruth McGowan 
 
 
 
  
Dear  
 
 
You are invited to take part in a research Study Investigating Women with Variations in the 
Development of the Reproductive System.  
 
This project is based at the Yorkhill Hospital and is supported by The Scottish Genital Anomalies 
Network (SGAN).  
 
Before you decide whether to take part, it is important for you to understand why the research is 
being done and what it will involve. Please take time to read the following information carefully. Talk 
to others if you wish.  
 
Part 1 of this information sheet tells you the purpose of this study and what will  
happen if you take part 
 
Part 2 of this information sheet gives you more detailed information about the  
conduct of this study 
 
Please feel free to ask us if there is anything that is not clear or if you would like more information. 
Take time to decide whether or not you wish to take part. 
 
We thank you for taking the time to read this. 
Sincerely 
 
 
Dr Ruth McGowan 
SpR Clinical Genetics, RHSC, Yorkhill 
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PART 1 
 
 
What is the aim of the study? 
 
The aim of this study is to find new mechanisms involved in the development of the female 
reproductive system in women. We hope to find new genes and proteins involved. This may allow us 
to work out how variations in known genes and proteins have their effect and offer women with 
variations in development of the reproductive tract more effective genetic counselling about risks of 
recurrence. 
 
We also wish to document changes that have occurred in other body systems such as bone, kidneys, 
etc. 
 
We would like to investigate the psychological impact of having a variation in the development of the 
reproductive system using standardised questionnaires. 
We also wish to interview a smaller group of women about their experiences of having abnormal 
development of the female reproductive tract. We want to find out their views as experts on their own 
lives. 
 
Why have I been chosen? 
 
We are approaching individuals identified through the SGAN register or by their local gynaecologist 
who have abnormal development of the female reproductive tract.  
 
Why is this study being done? 
 
Within the past twenty years, we have started to understand some of the processes that control the 
development of the reproductive system.  
 
These processes are controlled by proteins, such as growth factors in the testis or ovary, or 
hormones in the blood. These proteins are encoded by genes, which are regions of each person’s 
DNA blueprint or genetic code found on the chromosomes. Like DNA, RNA is made up of a long 
chain of building blocks. As in DNA, the sequence of building blocks allows RNA to encode genetic 
information. RNA molecules play an active role in cells, controlling gene activity and carrying the 
genetic information that directs the synthesis of proteins.    
By analysing the proteins/hormones, genes (DNA and RNA) and chromosomes of women with 
variations in reproductive development in more detail we hope to find new factors involved in 
reproductive development and help us to improve the diagnosis and management of individuals and 
families with reproductive system disorders. 
 
What will happen to me if I am interested in taking part? 
 
If you agree to participate in the study, we would obtain a small blood sample (one to two 
teaspoonfuls). This DNA (and RNA) will be stored and analysed for small changes in chromosome 
structure that may not be picked up on routine clinical tests. We hope this will uncover areas where 
there are specific genes related to the development of the female reproductive system. Some of 
these genes are currently known; others we hope to identify in the future. Wherever possible, we will 
take these blood samples at the same time that routine clinical tests are being done.  
 
It is already known that women with variations in development of the reproductive tract can have 
variations in other areas (kidney, bone and hormone levels.) If basic investigations of these areas has 
not been done we ask for your consent for us to arrange a renal ultrasound, and X-Ray of the spine 
and to collect urine and blood samples for hormone tests. This blood sample will be collected at the 
same time as blood is taken for DNA extraction. 
101 
 
 
Usually only single blood samples are requested, although we may request an extra sample from you 
if we find something we would like to investigate in more detail, and we may ask at a later date for 
additional blood samples to look at the hormone or protein pattern. We also may request a small 
sample of tissue to look at the DNA, RNA and protein pattern within the tissue. 
 
With your consent, we plan to keep the samples for other relevant studies in the future, if there is 
enough sample left. 
 
You will be invited to complete questionnaires that ask about quality of life and other factors. The 
answers will be reviewed by a Clinical Psychologist to see if variation in the development of the 
reproductive tract has any influence over general wellbeing. Further follow-up by Clinical Psychology 
can be arranged as is necessary.   
 
Your participation in this study will only require an additional clinic visit if you are not currently being 
seen at a clinic, although if you would like us to tell you any of our findings this may require slightly 
longer outpatients appointments, or a special appointment arranged with myself. 
 
We would also like to speak to a smaller number of you about your experiences of getting a 
diagnosis. It will only be possible to interview a smaller number of women because this will be more 
in-depth and will last between 45 minutes to an hour. The aim is to find out your experiences as an 
expert in your own life. We will ask questions about getting your diagnosis, talking to others about 
your diagnosis, how you feel about yourself, how others have reacted to you and dealing with 
intimacy. However we are also interested in other issues you might have.  
 
 
If you are happy to take part, and are satisfied with the explanations, you will be asked to sign a 
consent form. If you take part in the interview you will be asked to sign a form consenting to the 
interview being recorded. Interviews do not have to be recorded if you do not want them to be. You 
will be given a copy of the signed information sheet and consent/assent forms to keep for your 
records. 
 
What are the alternatives for diagnosis or treatment? 
 
There is now sufficient evidence that the tests proposed in this study would be considered in part of a 
standard of good clinical care. No routine tests or treatment would be withheld on the basis of 
whether you decide to participate in this study or not. 
 
What are the potential risks and disadvantages of taking part? 
 
No significant physical risk can be foreseen. We will try to take any blood samples at the same time 
that routine clinical tests are being performed. If a blood sample is being taken specifically for this 
study there will be some discomfort from the needle prick. If at any time you feel that the actual or 
perceived distress is too great, please don’t hesitate to tell your research investigator.  
 
As part of this study, you will be exposed to radiation from the bone X-rays. X-rays are used to form 
pictures of your body and provide more information to help your doctor. The level of dose from the X-
rays that you will receive is 0.5mSv compared to the dose of a chest X-ray, one chest X-ray being the 
equivalent of 0.03mSv. The dose is equivalent to what you would normally be exposed to in the UK in 
3 month’s natural background radiation. The main risk of exposure to X-rays is that a cancer may 
occur many years after the exposure. The risk from the amount of radiation you receive from these 
diagnostic tests is considered to be very low. 
 
Investigations may uncover some degree of abnormality and this could cause distress if participants 
are not prepared for this. Genetic studies may reveal an abnormality that could have implications for 
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the individual and their family members. It is possible that an abnormality identified may not be 
related to the study. The importance or implications of our genetic findings may not be known for 
some time. Further information related to genetic tests is provided in Part 2. Analysis of blood and 
urine samples may identify abnormal hormone levels and X-rays could reveal bony abnormalities.  
 
Any results will first be communicated to the individual by their main clinician. Subsequently this 
clinician will seek the advice from the multidisciplinary team (which includes several specialists) in 
discussing the results in more detail. Specific opportunity will be provided for counselling about any 
genetic abnormalities identified with a clinical geneticist. Women involved in the study will be given 
contact details of two clinicians who they can contact at any point during the study if they have any 
queries.  
 
Effort will be made to ensure that you feel as comfortable as possible as we understand that we are 
covering sensitive issue, however should you begin to feel distressed, you will be offered to 
opportunity to discuss this with a clinical psychologist. 
 
What are the possible benefits of taking part? 
 
There may be no immediate benefit to you taking part in this study, but our research will help us to 
understand the development of the reproductive tract in women better. This information may help 
other women with conditions affecting the reproductive system ensuring that they have appropriate 
investigations and when diagnosed. There is a small possibility, however, that we might find out more 
information related to your specific condition. You will have the option of how the results are given to 
you. You can choose whether we give you an aggregate result (for example, 3 out of 20 participants 
had interesting findings). You also have the option of not being informed about results. 
  
We will have the results of the “diagnostic” tests i.e. X-ray, renal ultrasound and hormone tests fairly 
quickly but the genetic tests may take up to 1 year as results need to be validated.  
 
Understanding more about people’s experiences should help services provide sensitive support and 
develop suitable interventions where required.  
 
What happens when the research study stops? 
 
We would like to keep any samples and relevant information related to this study for future research 
analysis beyond this current project. Undertaking further research work will be dependent on future 
funding. 
 
What will happen if I don’t want to carry on with the study? 
 
Your participation in this study is voluntary.  If you decide now or at a later stage that you do not wish 
to participate in this research project you are free to withdraw at any time, without giving any reason. 
Your medical treatment or legal rights will not be affected. Stored samples or any data collected will 
be destroyed if you wish.  
 
What if there is a problem? 
 
Any complaint about the way you have been dealt with during the study or any possible harm you might suffer 
will be addressed. The detailed information on this is given in Part 2. 
 
Will my taking part in the study be kept confidential? 
 
Yes. All information about your participation will be kept confidential. The details are included in Part 
2. 
 
This completes Part 1 of the Information Sheet. If you are interested in participating, please 
continue to read the additional information in Part 2 before making any decision. 
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PART 2 – Detailed information 
 
What if relevant new information becomes available? 
 
Your participation in this research study will not interfere with you being offered any relevant new 
tests or management approaches that might become available in the future.  
 
Will my taking part in this study be kept confidential? 
 
All information that is collected about you during the course of the study will be kept strictly 
confidential and in compliance with the Data Protection Act 1998. Any paper records will be stored 
securely and any electronic records bearing “identifiers” (e.g., names) will be password protected.  
 
Only the researchers and a representative of the Research Ethics Committee will have access to the 
data collected during the study. You will be asked to agree that appropriate sections of your medical 
notes may be looked at by responsible individuals from the researchers where it is relevant to this 
study.  
 
Notification of your General Practitioner (GP) and specialists involved in your care 
 
We will ask you for your permission to inform your GP and other specialists about your participation in 
this study. In some situations it will be important to discuss potentially significant research findings 
with other members of the clinical and research team, and other specialists involved in your care. 
 
If you show any signs of distress your GP will be notified and a referral can be made to a clinical 
psychologist.  
 
What will happen to any samples I give? 
 
Any samples provided will be processed and stored in the Clinical Genetics Laboratory at Yorkhill 
(DNA extraction and chromosomes), or in the Clinical Biochemistry Laboratory (serum/plasma/urine). 
 
Everyone taking part in this study will be given a study number (“coded”) and samples kept in the 
research laboratory will be handled on a day-to-day basis using this number. Only the research team 
involved in this study will have access to these samples, and only the principal investigator and 
designated individuals will be able to identify whose sample it is. 
 
We like to view any samples provided as “gifts” for the purposes of research. It is hoped that the 
samples will be kept for analysis by the research team on an ongoing basis, but it is quite possible 
that the samples will be used up during the course of this study. We also ask your permission to 
distribute coded samples and anonymous information to collaborators involved in related research 
within the UK, within the European Economic Area, and to countries outside of Europe. No names will 
be provided and you are free to choose whether you agree to this or not.  
 
We do not anticipate that this work will lead to any outcome of commercial significance and you would 
not benefit financially if this research does lead to the development of a new treatment or medical 
test. 
 
Information gathered in interviews and completed questionnaires will be kept in a locked filing cabinet 
for 10 years. Transcribed interviews will also be held on an encrypted computer for 10 years. 
 
Will any genetic tests be done? 
 
The aim of this study is to identify new genes involved in development of the female reproductive 
system, or variations in known genes involved in these systems.  
 
We will not be able to tell you the genes we plan to look at when you start the study but may be able 
to as the study progresses if a certain gene(s) is highlighted as being important in reproductive 
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development. We will also ask you whether we can analyse additional factors that may be relevant in 
reproductive biology as they are identified. You may allow us to do this without contacting you further, 
or you may request we contact you to get your agreement each time.  
 
Although this is a research study, we are willing to share any potential positive findings with you. If 
you would prefer not to know the results of any of our investigations then that is your choice. We 
recommend checking any positive findings in a separate sample, and – if you wish – trying to confirm 
our findings with further tests. However, it is possible that the significance of our findings is unclear at 
present. Finally, it is not currently possible to analyse all genes and proteins in their entirety, so we 
might overlook subtle changes in our studies.   
 
In a few instances, we are also trying to analyse many genes at once using a specially designed 
“gene chip” or similar technology. This new technology might be useful in the future for obtaining 
more rapid results for patients. If we are interested in including your DNA, RNA or protein in our study 
to test this new technology we will discuss it with you. 
 
What will happen to the results of the research study? 
 
Our aim is that the results of these studies will be presented to the scientific community and important 
advances will be published in peer-reviewed scientific and medical journals. This is the best way of 
having our work reviewed by experts in the field, and allowing other doctors and patients to benefit 
from our findings. 
 
You will not be identified in any report or publication unless you have consented to the release of 
such information. Clinical data, biochemical data (e.g. hormone results) and radiological (e.g. X-rays, 
scans), histological or whole-organ images (e.g. pictures of the gonad tissue), external photographs 
may be used.  
Direct quotations from interviews may be used in published reports, however it will not be possible to 
identify individuals from this as any identifiers will be removed and all information will be anonymous. 
 
What if there is a problem? 
 
If you are worried about any aspect of this study please discuss this in the first instance with the chief 
investigator (Dr Ruth McGowan, 0141 201 0808) who will do her best to answer your questions. 
There will also be a local specialist for you to contact and their details are at the end of this 
information sheet. If the problems are not resolved, or you wish to comment in any other way, please 
contact the Research and Development Office at the Tennent Institute, 38 Church Street, Glasgow 
(Kirsty Theron, 0141 211 6372). 
 
This project has been approved by an independent Research Ethics Committee who believe that it is 
of minimal risk to you. However, research can carry unforeseen risks and we want you to be informed 
of your rights in the unlikely event that any harm should occur as a result of taking part in this study.  
 
This research is covered by a no-fault compensation scheme, which may apply in the event of any 
significant harm resulting to you from involvement in the study. Under this scheme it would not be 
necessary for you to prove fault. You also have the right to claim damages in a court of law. This 
would require that you prove fault on the Hospital/Institute and/or any manufacturer involved. 
 
Who is organizing and funding the research? 
 
This study is being organized by Dr Ruth McGowan (Specialist Registrar in Clinical Genetics, RHSC) 
with other co-investigators including: Dr John Tolmie (Clinical Genetics, RHSC), Dr Wayne Lam 
(Clinical Geneticist, Western General Hospital, Edinburgh), Dr Faisal Ahmed (RHSC, Glasgow), Dr 
Miriam Deeney (Consultant Gynaecologist, Glasgow Royal Infirmary), Dr Edward Tobias (University 
of Glasgow),Dr Susie Logan (Consultant in Sexual and Reproductive Healthcare, NHS Grampian), Dr 
Rebecca Crawford (Clinical Psychologist, Glasgow Royal Infirmary), Ms Carolyn Espie (Trainee 
Clinical Psychologist, University of Glasgow), Professor Andrew Jahoda (University of Glasgow). 
Funding for the study shall be sought from organisations such as SGAN and other sources.  
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Who has reviewed the study? 
 
This study has been reviewed by the West of Scotland 4 Research Ethics Committee.  
 
If you are interested in taking part you will be given a copy of this information sheet and any 
signed consent form to keep. 
 
Please feel free to contact us if you have any further questions, or if your care moves to a 
different hospital or clinic. 
 
We thank you for considering taking part and for taking the time to read this information 
sheet. 
 
Contact:   
Dr Ruth McGowan                                Dr Susie Logan MD (comm),MRCOG,MFSRH                      Dr Wayne Lam 
Specialist Registrar Clinical Genetics  Consultant in Sexual and Reproductive Medicine                  Consultant Clinical Geneticist 
Ferguson-Smith Centre, Yorkhill          Square 13, 13 Golden Square                                               Western General Hospital 
Glasgow, G3 8SJ                                Aberdeen, AB10 1RH (Tel 01224 642711)                           Edinburgh, EH14 1JF                                                                                                                                 
(Tel: 0141 201 0808    Fax: 0141 0361)                                                                                             (Tel 0131 651 1013)                                                                              
e-mail: ruth.mcgowan@ggc.scot.nhs.uk 
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Appendix 2.3: Consent form 
Centre: RHSC, Yorkhill 
Study Number: ................. 
Patient Identification Number for this study:  
 
CONSENT FORM FOR PARTICIPANTS 
IN RESEARCH STUDIES 
 
Title of Project: Study Investigating Women with Variations in the Development 
of the Reproductive System 
 
Name of Principal Investigator: Dr Ruth McGowan 
 
                                     Please initial box 
                Yes       No              
 
1. I confirm that I have read and understand the information sheet entitled,                                                   
   “Study Investigating Women with Variations in the Development  
    of the Reproductive System.” for the above study.  
   I have had the opportunity to consider the information, ask questions and 
   have had these answered satisfactorily by ________________________. 
 
 
2.  I understand that my participation is voluntary and that I am free to withdraw at any                               
     time without giving any reason, without my medical care or legal rights being  
     affected. 
 
3. I understand that relevant sections of any of my Medical Notes and data collected                                  
    during the study may be looked at by employees from Regulatory Authorities or from  
    Royal Hospital for Sick Children, Glasgow where it is relevant to my taking part in this 
      research. I give permission for these individuals to have access to my records. 
 
 
4.   I agree to my GP to be informed of my participation in the study.                                        
 
 
5.   I agree to take part in the above study.                                                    
 
 
________________________ ________________ ____________________ 
Name Date of Birth Hospital number 
 
 ________________ ____________________ 
 Date  Signature 
 
_________________________ ________________ ____________________ 
Name of Person taking consent Date Signature 
(if different from Investigator) 
 
_________________________ ________________ ____________________ 
Investigator Date  Signature 
 
One copy for participant; one copy for R&D section in the Medical Notes; original to be kept in the PI’s site file 
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Centre: RHSC, Yorkhill 
Study Number: ..... 
Patient Identification Number for this study:  
 
CONSENT FORM FOR PARTICIPANTS 
IN RESEARCH STUDIES 
 
Title of Project: Study Investigating Women with Variations in the Development 
of the Reproductive System 
  
 
Name of Principal Investigator: Dr Ruth McGowan 
                                            Please initial box 
                 Yes       No 
 
6a. I agree to have a blood/saliva sample taken for DNA extraction.                                     
  
6b. I agree to my DNA sample being stored for future analysis.                                 
              
6c. I agree to my DNA sample being analysed on a research basis for other 
  genes that may be related to reproductive biology: 
 
 
  I) without further notification                       
  OR 
 
II)    I would like to be informed prior to additional analysis                                                 
        (if not in clinic, I would prefer telephone/letter/email [delete]) 
 
6d. I agree to my DNA being used to analyse multiple genes with the “Gene Chip”                                
 
6e. I agree to DNA/chromosome analysis for small rearrangements, deletions or duplications              
   
7a. I would like to be informed of the results of any positive research findings.                                 
 
7b. If yes (7a), I would like to receive any results in an aggregate format                                 
       (for example, 3 out of 20 people assessed were found to have interesting results) 
 
7c. If yes (7a), I would like to receive results specific to myself                                  
     (please note, these are research findings and do not represent a clinically approved test) 
 
 
________________________ ________________ ____________________ 
Name Date of Birth Hospital number 
 
 ________________ ____________________ 
 Date  Signature 
 
_________________________ ________________ ____________________ 
Investigator Date  Signature 
 
One copy for participant; one copy for R&D section in the Medical Notes; original to be kept in the PI’s site file 
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 Centre: RHSC, Yorkhill 
Study Number: ........ 
Patient Identification Number for this study:  
 
                    CONSENT FORM FOR PARTICIPANTS      
                          IN RESEARCH STUDIES 
 
Title of Project: Study Investigating Women with Variations in the Development 
of the Reproductive System 
 
Name of Principal Investigator: Dr Ruth McGowan 
                             Please initial box 
                   Yes       No 
 
 
8a. I agree to have a blood sample(s) taken for serum/plasma extraction, stored                                 
      and analysed for hormones and proteins that may be related to reproductive biology. 
 
9a. I agree to have a urine sample(s) taken, stored and analysed for hormones                             
      and proteins that may be related to reproductive biology. 
 
10a.I agree to my samples (for example, DNA, serum/plasma) being kept and used in                      
       future ethically approved research projects.   
 
11a.I agree to other radiological investigations being carried out to look for any abnormality  
       in the renal system and with the spine, including: 
   
 I. X-rays of the spine                          
    
 II. Renal ultrasound                          
 
 
       
12a. I agree to my clinical information including the use of external photographs and                                       
        research results being used in scientific presentations and journal publications.  
        No names or specific identifiers will be used.  
 
 
________________________ ________________ ____________________ 
Name   Date of Birth Hospital number 
 
 ________________ ____________________ 
 Date  Signature 
 
_________________________ ________________ ____________________ 
Investigator Date  Signature 
 
One copy for participant; one copy for R&D section in the Medical Notes; original to be kept in the PI’s site file 
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Centre: RHSC, Yorkhill 
Study Number: ..... 
Patient Identification Number for this study:  
 
CONSENT FORM FOR PARTICIPANTS 
IN RESEARCH STUDIES 
 
Title of Project: Study Investigating Women with Variations in the Development 
of the Reproductive System 
  
 
Name of Principal Investigator: Dr Ruth McGowan 
                              Please initial box 
                 Yes       No 
 
13a. I agree to have a blood/saliva sample taken for RNA extraction.                                   
 
13b. I agree to my RNA sample being stored for future analysis.                              
              
13c. I agree to my RNA sample being analysed on a research basis for other 
        genes that may be related to reproductive biology: 
 
 
 I) without further notification                                    
 
 OR 
 
 II) I would like to be informed prior to additional analysis                                                
  (if not in clinic, I would prefer telephone/letter/email [delete]) 
 
14a.   I agree to my tissue being taken to analyse genes/protein patterns                                              
 
14b.   I agree to my tissue being stored for later analysis                                                                        
 
 
 
 
 
 
________________________ ________________ ____________________ 
Name Date of Birth Hospital number 
 
 ________________ ____________________ 
 Date  Signature 
 
_________________________ ________________ ____________________ 
Investigator Date  Signature 
 
One copy for participant; one copy for R&D section in the Medical Notes; original to be kept in the PI’s site file 
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Centre: RHSC, Yorkhill 
Study Number: ..... 
Patient Identification Number for this study:  
 
CONSENT FORM FOR PARTICIPANTS 
IN RESEARCH STUDIES 
 
Title of Project: Study Investigating Women with Variations in the Development 
of the Reproductive System 
  
 
Name of Principal Investigator: Dr Ruth McGowan 
            Please initial box 
       Yes       No 
 
14a. I agree to complete questionnaires about general psychological well-being                               
        and other factors                                                                                                                               
 
 
14b. I agree to the answers being reviewed by a Clinical Psychologist with expertise in working with women 
with variations in the development of the reproductive tract     
     
                               
 
14c. I agree to be contacted by telephone or letter by Clinical Psychology after completing the  
         questionnaires if required 
 
                        
 
15.  I agree to taking part in an interview concerning my experience of having a diagnosis 
       
                                
 
 
 
        
(There will still be an opportunity to request an appointment with Clinical Psychology even if this is declined at 
this stage) 
 
 
 
 
 
________________________ ________________ ____________________ 
Name Date of Birth Hospital number 
 
 ________________ ____________________ 
 Date  Signature 
 
_________________________ ________________ ____________________ 
Investigator Date  Signature 
 
One copy for participant; one copy for R&D section in the Medical Notes; original to be kept in the PI’s site file 
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Appendix 2.4 Invitation letter and reply slip for interview 
 
 
Carolyn Espie                                                                                                                                                  Dr R McGowan 
Trainee Clinical Psychologist                                                                                        Specialist Registrar Clinical Genetics                                   
Department of Mental Health and Wellbeing                                                                         Department of Clinical Genetics 
Gartnavel Royal Hospital                                                                                                                    Ferguson-Smith Centre 
1055 Great Western Road, Glasgow, G12 0XH                                                                             Yorkhill, Glasgow, G3 8SJ 
e-mail: c.espie.1@research.gla.ac.uk                                                                                                       Tel: 0141 201 0808 
                  email: ruth.mcgowan@ggc.scot.nhs.uk 
 
 
Title of Project: Study Investigating Women with Variations in the Development 
of the Reproductive System 
 
Name of Principal Investigator: Dr Ruth McGowan 
  
Dear  
 
Thank you for consenting to taking part in an interview regarding your experiences of your diagnosis as part of 
the above study.   
I have enclosed the study information sheet to remind you of what is involved in this interview. Areas relevant 
to this interview have been underlined. If you are still interested in taking part, please return a completed 
contact details form in the envelope provided. You will then be contacted to arrange a suitable time to attend 
for interview. 
Please feel free to ask us if there is anything that is not clear or if you would like more information. 
We thank you for taking the time to read this. 
 
Sincerely 
 
Carolyn Espie 
Trainee Clinical Psychologist 
Co-investigator for research study 
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Contact Details Form 
Please complete this form and return it in the stamped addressed envelope. You will then be contacted to arrange a 
suitable time to participate, 
 
Surname:     
 
First name(s): 
 
Address: 
 
Contact number: 
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 Appendix 2.5: Topic Guide 
Topic Guide 
 
Introduction 
• I am extremely grateful for you coming along today. I know you will have seen various medics 
since your diagnosis and will have had medical treatment, however I am really interested in 
hearing about your experiences and what having MRKH has meant for you. This area has not 
been talked about as much and it would be really helpful for us to learn more about this. So 
today I am keen to learn from your experiences and about what has been important to you. 
 
Context 
• I thought it might be helpful to start off by finding out about you and your life in general and 
wondered whether you could tell me a bit about you, those who are close to you and what 
you enjoy doing. 
 
Diagnosis 
• It has been really helpful to hear about your life and what is important to you. I would be 
really interested to hear about what happened when you first noticed anything different? 
- What made you concerned that something may be wrong? 
- What did you do when you became concerned/noticed this? 
- Who was the first person you spoke to about it? (link back to those people previously mentioned 
 
• What was your experience of being given a diagnosis of MRKH? (Information given, by whom, 
understanding, how felt) 
 
Affect on life 
• It’s interesting to hear about what happened when you first had concerns and about when 
you were initially diagnosed. I wonder how would feel that having MRKH has affected you or 
your life? 
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(if multiple aspects are noted these will be addressed in detail one by one) 
Talking to others 
• I’ve heard about when you first learned of your diagnosis and how it has affected you. I am 
also curious about your experiences of telling people about MRKH? 
If don’t tell people – What do you think they would say or think about you if you told them? 
(Relate to those people already mentioned and to general family and peers) 
• How, if at all, would you say MRKH affected things with your family and friends? 
  - And how, if at all, would you say it affects you current relationships? 
Identity 
• I wonder what your diagnosis, and all these experiences you have been telling me about, 
mean to you as a person? 
- How does having MRKH make you feel about yourself? 
- How do you feel about other people’s reactions to MRKH? 
Intimacy 
• It’s been really helpful to hear about your experiences of MRKH in relation to yourself and to 
others. I wonder if you could tell me about how your experience of intimate relationships may 
have been affected by MRKH? 
- How have you discussed your diagnosis with partners/ how do you feel about discussing 
your diagnosis with future partners? 
Future 
• Everything we have discussed has been so helpful to help me understand you experiences of 
having MRKH. I am also interested to hear whether you anticipate that MRKH will affect you 
in the future? 
Other areas 
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• I am keen to make sure that we have as full as understanding as possible about living with 
MRKH. Are there other areas which we have not yet discussed which are important in your 
experiences of having MRKH?  
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Appendix 2.6 Consent form – recording and use of quotations 
Centre: RHSC, Yorkhill 
Study Number: ................. 
Patient Identification Number for this study:  
 
CONSENT FORM FOR PARTICIPANTS 
IN RESEARCH STUDIES 
 
Title of Project: Study Investigating Women with Variations in the 
Development of the Reproductive System 
 
Name of Principal Investigator: Dr Ruth McGowan 
 
I would like to tape record this meeting with you. Anything that you say will be kept private and I will be the 
only one who will listen to the tape. If you do not want me to record the meeting that is okay, I will write 
down the things you say instead.  
 
                      Please initial box 
                                  Yes       No              
1. I am happy for this interview to be tape-recorded.                                   
  
 
2.  I am happy for anything I say to be used in the final report (it will not be possible                           
 to identify you from what you say). 
         
________________________ ________________ ____________________ 
Name Date of Birth Participant Number 
 
 ________________ ____________________ 
 Date  Signature 
 
_________________________ ________________ ____________________ 
Name of Person taking consent Date Signature 
(if different from Investigator) 
 
_________________________ ________________ ____________________ 
Investigator Date  Signature 
 
One copy for participant; one copy for R&D section in the Medical Notes; original to be kept in the PI’s site file 
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Appendix 2.7: Sample analysed interview extract 
Interviewer’s notes 
Altered confidence Louise: it, it stopped me, like I was a confident girl, I would go out I’d     
Interest other sex do the flirting and have a good laugh and, it’s mostly guy friends I  
Partner at time  have and I was with a boy when I got told all about it 
CE: mm hmm 
Ended relationship Louise: and that kind eh split us up, like I had split up wae him because   
Low self-worth  I didn’t feel as if he’d want to be with me anymore and, because I 
Worthless  couldn’t do anything, and I think it’s really, it did, it took a lot off, eh, 
Confidence in  me, like relationship wise as well. Still to this day I find it hard to even 
relationships   get in a relationship because it, I don’t think I’m ready for it yet 
CE: okay 
Difficult to talk about Louise: tae tell the person my problem. 
CE: mm hmm 
Concern about   Louise: When I say, ‘oh’, to a guy, ‘oh look I’ve got this problem’, I’ve, I  
partner reactions feel as if they are just going to be like that ‘ooft no thanks, don’t want to go - - 
will end relationship through it with you’, do you know what I mean 
CE: okay 
Knocked confidence  Louise: so I was kind of like, relationship wise it did knock me back. Em, 
– relationship  my confidence. But it’s, it started playing about wae my mind so I was like 
Mixed emotions  down one day and I’d be happy the next and then just really depressed and, I  
Hard to deal with don’t know, it just really took a lot from me so it did. It, like, it was bad, it  
    was really bad. 
CE: Okay. And you were talking a wee bit there about telling other people 
Louise: Mm hmm 
CE: about your diagnosis and you were saying that you’ve, that you eh, kind 
of, worry about partners 
Louise: mm hmm 
CE: and telling them. What is it that you think you are worried might happen 
if you did tell a partner? 
                          Louise: well, as I said I was going wae a boy, .. when I got told about my 
Previous positive  diagnosis and he was just totally fine with it, he was like ‘listen, I’m not with 
partner reaction you just because of the sex part of it, I’m not with you because of that’ he 
Knocked confidence    says ‘I’ll help you through it’. But I think it was because it did knock            
Not good enough confidence off me I was just like ‘no, I want you eh have someone better, I 
Feel unfair on partner/  want you be able to have a sex life, I don’t want you to be able to, I don’t 
holding back  want to be, like, not go through the stages that every man goes through, I  
                                     don’t want eh take that away from you’. So when I do like, go eh, like I’m, I   
    was seeing a boy a few month ago and when I was going to tell him it was 
Hard to tell/talk about  just, I was like, I couldn’t, and I was like ‘no’. Don’t think, I think it’s to do 
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Need trust  with trust and could I trust a boy not to run about telling everybody about it 
Personal/ don’t want because it’s really personal thing to me I don(‘t), I don’t want everybody  
others to know   knowing about it 
                                 
CE: sure 
Those close to know Louise: it’s mostly just family that know and my, one of my friends 
CE: mm 
Hard to talk about Louise: so, I, I just, I do find it hard tae .. opening up about it. But I think 
Worry about reactions what would happen like, if I did tell somebody that, they’d be like ‘oh no, I      
- end relationship don’t want to go wae you’ 
CE: okay 
End as can’t have sex Louise: like ‘I can’t have a sex life with you’ and then go. So I do find it 
Worry re reactions hard. 
- difficult 
CE: Mm hmm. But you were saying you did tell the, the person you were with 
Louise: yeah 
CE: yeah, m, yeah. 
Effect of lowered Louise: I ruined that myself (laughing) because I didn’t feel confident 
confidence on   enough and I was with a boy for a year and a half 
relationship 
CE: mm hmm 
Previous positive Louise: and he didn’t bother, he was like ‘I don’t care, I’ll help you through 
reaction   it. If we need to do what we need to do then that’s what we need to do’ kind  
    of thing, and then if we were sitting talking about having kids and stuff and 
Feel to blame/  [name of boyfriend] really wanted a ch, child, so I’ve, I kind a took that   
unfair on partner  away from him as well so I was kind of hurt by that and,. But then, when I 
Partner considering told him about not being able to carry he was like ‘we could get somebody 
other options  else to carry the baby, we can adopt, we can’ and he’d be saying so many 
Unfair on partner/ things and I just think I didn’t feel, I just felt as if ‘you should be able to have 
won’t have a  a normal life and just not have to worry about me constantly’ 
‘normal’ life 
CE: mm 
Confidence affected Louise: So I think that’s why I kind of finished it and stuff, coz I, my 
relationship  confidence, it just totally went, I just felt as if I was worthless. 
worthless 
 
CE: Okay, okay. And in what way, do you think, you fe(el), you feel or felt 
wor, worthless? 
Unable to have sex Louise: ... Em, I don’t know, I just felt as if, like, because I couldn’t have a   
    sex life, like most women do 
CE: mm hmm 
Can’t have child,sex Louise: So I felt as if because I couldn’t do that and (be)cause I couldn’t, like, 
Not complete woman    have children, that, I just felt, I didn’t feel part women, if you 
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CE: can you 
                         Louise: known what I mean. I don’t know, I, it was, it was weird like, the 
Range of emotions way I felt, like a totally different feeling running through me every day. So I 
Worthless  think it was, just weird for me, like I just felt worthless in a way, like I    
Unfair on partner couldn’t give my boyfriend they best, or couldn’t have a sex life with him 
CE: mm hmm 
Difficult in   Louise: so I found that quite hard for him and me because, even though I did 
relationships  love him, I loved him to pieces, like, everybody says ‘you don’t know what 
Hard consequences love is when you’re younger’, like I did really love him, my mum noticed      
in relationships  that. When we finished I think my mum knew it was because of my problem     
Hurt   and my diagnosis and stuff. I think she realised, she’s hurt 
CE: yeah 
Hold partner back  Louise: like, she doesn’t, she wants to let him have a normal life, so. 
Not normal 
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Appendix 2.9 Themes and dimensions 
Theme Dimensions 
 
 
Hindering independence 
 
(i) Personal nature of MRKH 
(ii) Mothers involvement in diagnostic process 
(iii) Professionals disregard for growing autonomy 
(iv) Undermined wish for privacy 
 
 
A sensitivity to difference 
 
(i) Emotional reactions to difference 
(ii) Social situations as triggers for thinking about diagnosis 
(iii) A need to talk to others with MRKH 
 
 
 
Managing intimacy 
 
(i) Negotiating when to tell partners 
(ii) Concners about negative reactions 
(iii) Avoidance of intimacy 
 
 
Managing threat to identity; 
dealing with a disrupited 
developmental process 
 
(i) Affected female identity 
(ii) Affected self-esteem 
(iii) Managing presentation of self 
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Appendix 2.10 Major Research Project Proposal 
 
Exploring the short term psychological impact of Mayer-Rokitansky-Kuster-Hauser (MRKH) 
syndrome; an interpretational phenomenological analysis approach 
 
Abstract 
Background  Mayer-Rokitansky-Kuster-Hauser (MRKH) is a congenital condition diagnosed 
in adolescence when a female’s vagina and uterus do not develop. Many studies have noted 
a strong psychological impact of MRKH however few have examined this explicitly. As 
gender identity and social acceptance are particularly salient during adolescence it is 
proposed MRKH may provide unique challenges at this life stage. 
 
Aims  This study aims to examine young people’s experience of having MRKH, particularly 
the social and emotional challenges and impact on their identity. 
 
Methods      A semi-structured interview following a topic guide will be completed with 8-10 
women diagnosed between 6 months and 5 years previously and will be analysed using 
Interpretational Phenomenological Analysis. 
 
Applications   Understanding the challenges a diagnosis of MRKH places on adolescents 
should inform management of women with the condition, and enhance the development of 
sensitive and timely interventions. 
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Introduction 
Mayer-Rokitansky-Kuster-Hauser (MRKH) is a congenital condition where, although females 
have normally functioning ovaries, the vagina and uterus do not develop (Edmonds, 2000). 
The condition is relatively rare, occurring in around 1 in 5000 females (Edmonds 2003). 
Diagnosis tends to be in mid-adolescence when secondary sexual features have developed 
but menstruation has not begun (Aittomaki, Eroila & Kajanoja 2001; Mungadi, Ahmed, 
Yunuse et al. 2010). 
 
Many studies have noted a strong psychological impact of having MRKH with Edmonds 
(2003) recommending that management should involve supporting women to cope with the 
impact of the condition. However, the majority of studies have employed a medical 
approach, looking at outcomes in terms of surgical and non-surgical treatments to create a 
neovagina (Bean et al. 2009). Hence, enhancing the understanding of the psychological 
impact of MRKH should assist services in developing more sensitive and effective care for 
this population. 
 
The majority of research concerning diagnosis of long-term conditions has focused on those 
which have continuing, often serious, health implications, such as cancer. Leventhal’s (1984) 
‘self-regulation model’, is a commonly used model of adjustment to chronic illness and 
proposes that people’s interpretation of the health threat has an effect on adjustment. 
According to this model, five areas determine an individual’s cognitive representation of the 
health threat, namely the identity or label they give the condition, the perceived cause, 
believed consequences, timeline of the illness, and belief about controllability and cure. 
These cognitive representations have been found to predict illness outcome, including 
psychological well-being (Hagger & Orbell, 2003). This model however has not been applied 
to conditions such as MRKH which, although life changing, do not have serious health 
consequences or require long term pervasive treatment. It is therefore important to look at 
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the unique challenges of MRKH and whether adjustment to this may differ from the 
conditions Leventhal’s model applies to.  
 
Using Interpretational Phenomenological Analysis (IPA), Holt and Slade (2003) found four 
themes to emerge for women who had been diagnosed with MRKH between two and 22 
years previously, namely dealing with loss, experience of medical services, sharing with 
others, and the role of time. In a recent review, Bean et al (2009) found only 11 articles 
focused on the psychological effects of MRKH with ‘infertility’, diagnosis, adjustment and 
coping strategies, family responses, self-concept and view of self as female being found to 
be the most challenging aspects. Kimberley, Hutson, Southwell & Grover (2011) found 79% 
of their sample, aged between 16 and 71 years old, reported that being unable to carry a 
pregnancy the most distressing feature of their diagnosis. These studies suggest that having 
a diagnosis of MRKH challenges women’s identities. Indeed, in a review, Heller-Boersma 
(2006) concluded that adjusting to MRKH is difficult and traumatic, causing women to 
question their female identity and feel confused about their social and sexual roles. From 
these studies, it seems that adjustment to MRKH does not easily follow Leventhal’s model. 
Although MRKH is a physical condition, the impact appears to be psychological and largely 
relate to social roles rather than health per say. Having MRKH is not visible to others, but it 
fits with Goffman’s (1959) notion of a hidden stigma. Consequently, women with MRKH may 
try to keep their diagnosis secret in order to avoid anticipated negative consequences from 
others. 
 
The studies reviewed by Bean et al. (2009) have a wide range of ages. However, it is likely 
that different challenges may be salient at different life stages, for example being unable to 
carry a child may be more distressing for older females than adolescents. Indeed, time came 
out as a theme in Holt and Slade’s study and Heller-Boersma found women to be most 
distressed immediately after diagnosis; unsurprisingly accounts changed as time passed. It 
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is therefore important to explore the unique challenges faced at different phases following 
diagnosis, including the initial period of adjustment. 
 
As previously mentioned, diagnosis usually occurs in adolescence where Erikson (1968) 
proposed that the key developmental task for young people is forming a consistent identity 
and avoiding role confusion; being sure of who they are and how they fit into society. Marcia 
(1966) further developed Erikson’s concepts and proposed that adolescents move through 
identity stages, beginning with identity diffusion and reaching identity achievement once 
crisis has been resolved and the person is committed to their identity. Marcia found those 
who have progressed to identity achievement were more resistant to stress and less affected 
by receiving negative information about themselves (1966, 1967). Both Erikson and Marcia 
therefore propose that individuals experience an identity crisis before their identity is formed 
and that individuals are vulnerable during this period.   
 
Adolescence has been consistently thought to be the life stage associated most with 
transition and rapid cognitive, social and physical changes, and where sense of self is more 
salient (Jessor, 1984; Descombe, 2001; Brown, 2004; Sebastian, Burnett & Blakemore, 
2008). For example, physical changes in adolescence involve individuals becoming 
reproductively mature, beginning when secondary sexual characteristics develop and 
finishing when fully capable of reproduction (Brinthaupt & Lipka, 2002). Social changes 
include becoming more independent, spending less time with their parents, and more time 
with their peers, and developing more romantic and sexual relationship (Larson & Richards, 
1991, Bee, 1975, Engels & van den Eijnden, 2007).  
 
These physical changes have been found to cause many concerns, for example physical 
changes relate to worry about gender adequacy and sense of self as male or female, with a 
sense of inadequacy being related to depression and anxiety as well as poorer adult 
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adjustment (Brinthaupt & Lipka, 2002; O’Heron & Orlofsky, 1990; Aubé & Koestner, 1992). 
Sex role identity, determined by whether the individual fits the roles used within their culture 
to determine male or female behaviour, is also a salient issue (Paul & White, 1990).  The 
increased focus on social and romantic relationships has been found to relate to being more 
susceptible to feeling inadequate, fearing peer rejection, and to increased expectations for 
closeness (Seiffge-Krenke, 1998, Engels, 2007).  Adolescents may worry about other’s 
reactions to their diagnosis of MRKH as it breaks social norms relating to gender identities. 
Consequently they may try to conceal their diagnosis from others to avoid being stigmatised. 
The social impact of MRKH for adolescents has, however, not been studied. 
 
It therefore seems that irrespective of whether an identity crisis is experienced, 
adolescents face many challenges and this physical and social process can cause 
them to question their identity. As gender identity and social acceptance are salient, a 
diagnosis of MRKH which truly challenges an individual’s identity may cause an 
additional trauma. There may be particular challenges for adolescents with MRKH 
which lead to greater distress around the time of diagnosis and prolonged identity 
confusion. Kroger (2004, 2010) proposes that identity development may not be 
achieved by early adolescence, because particular circumstances may mean many 
addition hurdles have to be overcome.  This study will therefore specifically explore 
young people’s experience of having a diagnosis of MRKH in order to understand 
their experiences at this critical stage of adolescent development 
Qualitative approaches aim to explore individuals’ lived experiences. The particular approach 
to be taken in this study is IPA (Smith, 1996), a method that often deals with significant and 
emotional life changing experiences (Smith & Osborne, 2003). IPA has been found to be 
effective in exploring health and illness, sexuality, psychological distress, life transitions and 
identity (Smith & Osborne, 2008). IPA should be employed with a discrete, homogeneous 
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group (Smith & Osborne, 2007), therefore this study will focus on those diagnosed with 
MRKH the past five years to capture the experiences of adolescents at this specific stage.  
 
It is hoped that findings from this study should inform the management of adolescents with 
MRKH and aid the development of sensitive and timely interventions. 
 
Aims 
The study aims to explore young women’s experiences of having MRKH to address the 
following broad research questions; 
- What are young people’s experiences of having a diagnosis of MRKH? 
- What are the social and emotional challenges faced by young people with a diagnosis of 
MRKH (including family and peer relationships)? 
- How do individuals manage a diagnosis of MRKH in relation to their developing identities? 
 
Plan of Investigation 
Design 
Data will be analysed using Interpretational Phenomenological Analysis (IPA). This approach 
was chosen to allow descriptive and detailed reports of individual experiences (Smith & 
Osborne, 2007). IPA is phenomenological in that it concerns individual’s personal reports of 
their experiences yet recognises the interpretative element of the researcher analysing data.  
 
Participants 
8-10 females with MRKH will participate. As this is a qualitative study a power calculation 
was not appropriate, and the sample size follows the recommendations for IPA studies. 
Smith, Jarman & Osborne (1999) recommend 10 participants to be at the larger end of 
appropriate sample size and Smith (2003) reports typical sample sizes of 6-12 participants. 
These small sample sizes allow for a detailed interpretative account of each participant’s 
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experiences (Smith and Osborne, 2008). The number should also allow for data saturation, 
that is when no new themes are emerging. 
 
Inclusion and Exclusion Criteria 
Participants must be female, aged 16 and over, and have had a formal diagnosis of MRKH 
at least 6 months prior to being interviewed to allow for the initial shock to be resolved.  
Participants must not have had a diagnosis for over 5 years. Those aged over 30 and those 
who do not speak English as their first language will be excluded from the study. As 
individuals usually receive a diagnosis of MRKH in mid-adolescence and we are looking to 
recruit only those diagnosed within the last 5 years, it is likely that in reality the age range of 
the sample will be closer to 16 – 25 years. The sample will have as narrow an age range as 
possible. These criteria are being used to ensure the group is homogenous and to determine 
particular experiences at this time. 
 
Recruitment Procedures 
This study will be linked to a multicentre genetic study for women with congenital 
abnormalities with sites in Glasgow, Edinburgh, Aberdeen and Leeds. Individuals on the 
Scottish Genetic Anomaly Network (SGAN) database are being invited to participate in this 
genetics study and it is expected that around 40 women will be recruited from the Scottish 
sites and a further 40 from Leeds. Within the ethical approval for the multicentre study, 
participants will be asked to consent to both genetic and psychological assessments. They 
will also be asked whether they agree to being contacted about taking part in an open-ended 
interview to describe their experiences.  
 
For the current study, those who have consented to being contacted and who received their 
diagnosis between 6 months and 5 years previously will be sent an information pack about 
this study with a telephone number and a stamped addressed envelope to contact the 
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researcher, should they be interested in participating. The information sheet will inform 
potential participants that, if possible, we would like to record interviews. As participants 
have already agreed to being contacted about this study, they will be telephoned to ask if 
they would like to participate if there has been no response after two weeks.  
 
Those who consent to taking part will be asked to meet the researcher at the study site 
which is closest to them. Participants will be given at least 24 hours to consider the 
information sheet and consent form before being asked to give consent to taking part and to 
the interview being recorded. It is anticipated that the interview will last approximately 45 
minutes. 
 
Semi-Structured Interview 
In line with IPA, a non-directive, semi-structured interview will be used. As this study 
concerns a very sensitive topic with young women, pilot work will be carried out to find ways 
to develop a dialogue that allows them to express their views openly. Tasks such as using 
cards with different statements and asking the participants to sort them into piles depending 
upon whether it is information they would or would not share with their friends or family might 
be included as a way of stimulating discussion. This sorting type task would be used as a 
prompt for discussion rather than to generate data, therefore this data will not be analysed, 
The first two interviews will be considered as pilots, but if successful it may be possible to 
include the data in the final analysis. Care will be taken to make it clear to the young women 
that the researcher is interested in their views as experts on their own lives. 
 
A paper topic guide, based on guidance from experienced clinicians working in the field and 
from past research, will be used to help structure the dialogue. However the interview will 
remain alive to different topics raised by the participants themselves and will b discussed 
fully. It is planned that the draft topic guide will be as follows: 
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(i) Social context (family composition, family life, friendships)  
(ii) Diagnosis (initial understanding, information given,) 
(iii) Talking to family (family reactions and communication) 
(iv) Talking to friends (puberty and diagnosis) 
(v) Identity (personal meaning, how the diagnosis makes them feel about themselves 
and the reactions of others to them, both actual and anticipated) 
(vi) Dealing with intimacy 
The social context will be covered at the start of the interview to gain insight into individual 
contexts and to help participants relax before discussing more sensitive topic. Beyond this, 
topics will be covered as they are raised by the participant. Participants will also be given the 
opportunity to discuss any other issues not yet raised.  
 
Measures 
As the proposed study is linked to the wider genetics study, there will be permission to 
access participant information held on the SGAN database such as ages, post codes (to 
determine socio-ecomomic status using the Scottish Index of Multiple Deprivation and the 
English Index of Deprivation), and time since diagnosis. The Hospital Anxiety and 
Depression Scale (Zigmond and Snaith, 1983), a widely used self-report measure, will be 
completed as part of the genetics study and therefore scores for anxiety and depression will 
be available. In line with previous literature it is not expected that large numbers of 
participants will have clinical levels of difficulty, however a characteristic of the sample is 
likely to be elevated levels of distress compared to the general population (Laggari et al, 
2009, Heller-Boersma, Schmidt Edmonds, 2009). This background information will be used 
to situate the sample. 
 
Research Procedures 
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Interviews will be held in a clinic room at one of the sites where the genetics study is being 
run. The interview will last approximately 45 minutes.  
 
Settings and Equipment 
Interviews will take place in clinic rooms at the various study centres. Where consent is 
given, interviews will be recorded and transcribed verbatim.   
 
Data Analysis 
Transcripts will be analysed using IPA, as described by Smith & Osborne (2008). Transcripts 
will be closely read and points of interest and significance will be noted line by line. 
Transcripts will then be re-read and themes will be noted. Emerging themes for each 
interview will be compared and integrated. The key concepts that emerge will be used as the 
basis for writing the final report, with appropriate quotations being selected to serve as 
illustration.  
 
To ensure the process is rigorous and transparent a reflective journal will be kept to record 
decisions made when selecting themes and key concepts. Themes and concepts will also be 
compared against summaries of each individual interview, including reflective written notes, 
to ensure individual experiences are described. Identified themes will be discussed in 
research meetings as a means of audit (Elliott, Fischer & Rennie, 1999; Reid, Flowers & 
Larkin, 2005). Two transcripts will also be marked by the academic supervisor as a second 
rater. 
Health and Safety Issues 
No health and safety issues are anticipated. In order to maintain a safe and private 
environment where the participant can feel comfortable, interviews will be held in a NHS 
clinic room within working hours when other staff will be in the building.  
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Ethical Issues (including where submissions will be made) 
An application will be made to the West of Scotland Research Ethics Committee 4 for ethical 
approval. This application will be linked to the study ‘Spectrum of Clinical and Genetic 
Abnormalities in Women with Congenital Abnormalities of the Female Reproductive Tract’. 
 
Informed written consent will be sought from all participants entering the genetic study and, if 
asked to attend a semi-structured interview, participants will be asked to sign a consent form 
for the interview to be recorded. All participants will be given a copy of their signed form. 
Participants will be informed that they can withdraw consent at any point. 
 
Information will be treated in a confidential manner, with all participants being assigned a 
participant number. Direct quotations from interviews will be included in the final report, 
however no identifiable information will be given. Data will be stored on a University of 
Glasgow laptop, encrypted to NHS standards. Paper copies of anonymous data will be 
stored in a locked filing cabinet at the Department of Psychological Medicine, University of 
Glasgow.  
 
The researcher understands that this is a very sensitive topic area and participants may feel 
embarrassed or find it hard to discuss these issues. The researcher will remain aware of this 
and will approach topics in a sensitive and incremental fashion. Pilot work will address this 
issue and tasks may be used within the interview to help prevent participants from feeling too 
self-conscious, At the end of the interview time will be taken to ask if there is anything else 
the participant would like to talk about and to check how the participant is feeling. All 
participants will be provided with a summary of the findings from the study and will be given 
the opportunity to contact the researcher to discuss this. If any participants show signs of 
distress, an onward referral will be made to the clinical psychologist linked to the study at the 
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relevant centre and their GP will be notified with the participant’s consent. This procedure will 
be discussed with participants prior to consenting to taking part in the study. 
 
Financial Issues 
Rooms will be available at the centres involved in the study with no cost. A voice recorder 
and foot pedal will be required to record and transcribe interviews. There will also be costs of 
posting information and letters to participants. No monies are being requested for travel 
costs to Leeds. 
 
Timetable 
Submission for ethical approval February/March 2011 
Pilot study to develop interview guide September 2011 – October 2011 
Data Collection October 2011 – March 2012 
Analysis and write up March 2012 – June 2012 
Submission of project June 2012 
 
Practical Applications 
Knowing more about the social and emotional challenges a diagnosis of MRKH places on 
adolescents should inform service development. Further, this greater understanding should 
enhance the development of therapeutic approaches for this population. 
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